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ABSTRACT
Salt-sensitive individuals have blood pressure that is unusually sensitive to salt intake. Because
salt-sensitivity is a common disorder and may cause high blood pressure, it is a significant public
health concern. All three epithelial Na+ channel (ENaC) subunits (α, β, and γ) and the
mineralocorticoid receptor (MR), a known regulator of ENaC, are expressed by vasopressin (VP)
synthesizing magnocellular neurons in the hypothalamic supraoptic (SON) and paraventricular
(PVN) nuclei. A growing body of evidence indicates that epithelial Na+ channels (ENaCs) in the
hypothalamus play a significant role in the development of salt-sensitivity. My dissertation
research tests the hypothesis that abnormal ENaC regulation occurs in VP neurons during saltsensitive hypertension. To investigate this, I first used acute hypothalamic slices in an in vitro
model to elucidate the ENaC regulatory mechanism present in the VP neurons of normotensive
rats. Findings from this study demonstrated that aldosterone binds to the MR to directly interact
with the promoter region of the γENaC gene to increase protein abundance in VP neurons, but
aldosterone alone does not alter the ENaC-mediated current in VP neurons. To examine ENaC
regulation during salt-sensitivity, Dahl salt-sensitive (Dahl-SS) and normotensive SpragueDawley (SD) rats were fed high salt diet to determine if any abnormal responses in the expression
of ENaC subunits and MR occurred in the hypothalamus and kidney in response to a high dietary
salt intake. Dietary salt intake caused a significant hypothalamic upregulation of γENaC in saltsensitive animals and promoted proteolytic cleavage of the γENaC subunit. In contrast, the same
dietary regimen caused significant downregulation of hypothalamic MR and kidney αENaC
expression in normotensive animals. These results indicate a possible compensatory mechanism
for salt-sensitive hypertension development present at the level of the hypothalamus of
normotensive animals, which is not observed in salt-sensitive animals. Taken together, findings

ix

from my research suggest that high salt diet initiates a central pathway involving aldosterone-MRENaC in salt-sensitive animals to affect VP neuronal activity and contribute to hypertension
development.

x

CHAPTER 1
INTRODUCTION
Overview
Salt sensitive hypertension affects 20-30% of the general population (Franco & Oparil,
2006). Individuals diagnosed with salt-sensitivity experience an abnormal increase in blood
pressure in response to dietary salt intake. Salt sensitive individuals, regardless of hypertension
development, are at a higher risk of cardiovascular disease and reduced survival (Weinberger et
al., 1986; Weinberger et al., 2001). Although the etiology of salt-sensitivity is not well
understood, a growing body of evidence suggests that abnormal regulation of central epithelial
sodium channels (ENaC) contributes to the development of this disease state (Gomez-Sanchez &
Gomez-Sanchez, 1994, 1995; Nishimura et al., 1998). Expression of ENaC has been
demonstrated in vasopressin and oxytocin synthesizing magnocellular neurons (Teruyama et al.,
2012a) that are present in the hypothalamic supraoptic (SON) and paraventricular nuclei (PVN).
The studies in chapters 2 and 3 investigate the role of hypothalamic ENaC expression in saltsensitive hypertension and the possible mechanism(s) involved in regulating hypothalamic ENaC
expression in vasopressin- synthesizing neurons.
Vasopressin
In response to changes in the blood osmolality, mammals alter their behavior and
physiology. Changes in thirst and sodium appetite are behavioral responses to aid in the
regulation of sodium and water balance (Robertson & Athar, 1976; Robertson, 1984; Thompson
et al., 1986). Additionally, changes in renal excretion of water and sodium are mediated by
altering plasma concentrations of multiple hormones. An essential hormone involved in this
process is the antidiuretic hormone, or vasopressin. A member of a hormone superfamily that is
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expressed in vertebrates and invertebrates (Roch et al., 2011), vasopressin is semi-cyclic
hormone composed of nine amino acids and is responsible for regulating urine solute
concentration to maintain body-fluid homeostasis (Antunes-Rodrigues et al., 2004) and
cardiovascular control. Additionally, vasopressin been has shown to be is involved in the
regulation of social behaviors (Ferris, 2005), carbohydrate metabolism (Al-Barazanji et al.,
1998), and thermoregulation (Richmond, 2003).
Synthesis and release of vasopressin
Vasopressin is a neurohypophysial hormone synthesized by magnocellular
neurosecretory cells (MNCs) in the SON and PVN in the hypothalamus (Hara et al., 1990; Ratty
et al., 1996). The SON is entirely comprised of MNCs, whereas the PVN is divided into a MNCs
subdivision and a parvocellular subdivision (Swanson & Sawchenko, 1983). Vasopressin is
transported in the axons of MNCs to the blood capillaries of the posterior pituitary (Bargmann,
1951) for release into general circulation to mediate a variety of physiological mechanisms (Du
Vigneaud, 1954). The release of vasopressin is enhanced during times of hyperosmolarity
(Brimble & Dyball, 1977), hypovolemia (Harris et al., 1975), and hypotension (Khanna et al.,
1994) to produce pressor and antidiuretic effects to counter the physiological changes (AntunesRodrigues et al., 2004). Vasopressin neurons fire in a rhythmic or phasic pattern alternating
between periods of activity, or “bursts”, followed by a period of inactivity, or “silence” (Dutton
& Dyball, 1979). Synthesis and release of vasopressin into the general circulation via the
neurohypophysis is promoted by the physiological demands of maintaining body fluid
homeostasis (Poulain & Wakerley, 1982). The phasic activity is not coordinated amongst groups
of vasopressin neurons leading to asynchronous firing and a continuous release of vasopressin
into circulation rather than a pulsatile release (Leng & Dyball, 1983).
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Vasopressin receptors
There are currently three subtypes of vasopressin receptors that have been identified and
all are seven transmembrane domain, G-protein-coupled receptors that are expressed in a variety
of tissues. The V1a receptor is expressed in multiple tissue types, including multiple regions of
the brain, vascular smooth muscle, cardiac myocytes, testes and kidney (Morel et al., 1992;
Ostrowski et al., 1992; Morel et al., 1993). Activation of the V1a receptor by vasopressin
binding in the vasculature results in pressor effects, which are primarily detected in the renal and
hepatic arteries. Unlike the V1a receptor, theV1b receptor has a limited distribution and is most
abundantly expressed in the anterior pituitary gland where it is involved in the release of
adrencoticotropin (Tanoue et al., 2004). Additionally, the V1b receptor is expressed in the
adrenal glands, kidneys, and pancreas (Sugimoto et al., 1994). The V2 receptor is abundantly
expressed in the basolateral membrane of principle cells in the renal collecting duct (Lolait et al.,
1992). Binding of vasopressin to the V2 receptor results in the trafficking and insertion of
aquaporin channels into the luminal membrane of the principle cells to promote water
reabsorption to affect urine concentration (Birnbaumer et al., 1992; Lolait et al., 1992).
Role of vasopressin in central autonomic control of blood pressure
The parvocellular subdivision of the PVN sends projections to the intermediolateral
column of the spinal cord (IML) and the rostral ventrolateral medulla (RVLM) to mediate
sympathetic outflow to the cardiovascular system. In addition to being released from the
neurohypophysis, vasopressin is also released somato-dendritically by MNCs in the PVN to
increase the activity of parvocellular neurons that project to the RVLM (Son & Stern, 2011).
This action, in turn, affects sympathetic outflow and blood pressure (Dampney, 1994).
Application of VP into the PVN significantly increased sympathetic nervous system activity and
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blood pressure (Martin et al., 1985), which has been shown to be attenuated with V1a receptor
antagonists (Rossi & Maliszewska-Scislo, 2008; Lozic et al., 2016). V1a receptors are expressed
in the IML, a region of the spinal cord that contains the bodies of sympathetic preganglionic
neurons (Sermasi et al., 1998). This expression pattern further demonstrates the central role that
vasopressin release has on mediating autonomic control of blood pressure. It should be noted that
vasopressin released into general circulation does not significantly contribute to mediating blood
pressure under basal physiological conditions (Hirsch et al., 1993).
ENaC
The non-voltage dependent and amiloride-sensitive channel, ENaC is a member of the
degenerin/epithelial sodium channel (Deg/ENaC) superfamily and is composed of three subunits
(α, β, and γ) that form a highly selective Na+ channel (Canessa et al., 1994). ENaC is expressed
in the apical membrane of epithelia involved in trans-epithelial Na+ transport (Canessa et al.,
1994; Harris et al., 2008), such as in the renal collecting duct, distal colon, and respiratory
epithelium (Farman et al., 1997; Kellenberger & Schild, 2002). ENaC mediated Na+ transport is
passive and depends on the electrochemical gradient for Na+ established by the Na+/K+ ATPase
located on the basolateral membrane (Palmer et al., 1980; DeLong & Civan, 1984; Bens et al.,
1999; Rubera et al., 2003) (See Fig. 1.1). One of the main roles of functional ENaCs is to aid in
maintaining salt and water homeostasis at the level of the kidneys where it precisely regulates
sodium reabsorption to regulate blood pressure and extracellular fluid volume (Rossier, 2014).
Structure of ENaC
For ENaC to have full activity, all three subunits must be expressed (Canessa et al., 1994;
McDonald et al., 1994; Snyder, 2000). The exact stoichiometric of the channel remains
unknown. However, it is generally accepted that all three of the subunits are involved in the
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formation of a functional pore (Canessa et al., 1994; Firsov et al., 1998) and several lines of
evidence suggest a heterotetrameric structure of the channel comprised of 2α, 1β, and 1γ
subunits (Firsov et al., 1998; Dijkink et al., 2002; Anantharam & Palmer, 2007) or 3α, 3β, and
3γ subunits (Snyder et al., 1998; Eskandari et al., 1999).

Interstitial space

+

Na

collecting duct
principal cells

Na-KATPase
ENaC

K

+

+

Na

Tubular Lumen / apical side

ENaC

Na

+

+

Na

Na-K-ATPase

K

+

+

Interstitial space

Na

Fig. 1.1. A sketch representation of the movement of Na+ ion in the distal collecting tubule.
ENaC facilitates the flow of Na+ ions across the luminal membrane into the cytoplasm of
epithelial cells. The absorbed Na+ ions are then pumped out of the epithelial cell into the
interstitial space via Na+/K+ ATPase located on the basolateral membrane. Movement of the Na+
ions via ENaC has a central role in the regulation of extracellular volume and blood pressure.
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ENaC subunits share approximately 30- 40% amino acid sequence homology (Canessa et
al., 1994) and have similar protein structures with molecular masses between 70-85 kDa
(Alvarez de la Rosa et al., 2000; Sun et al., 2011). ENaC subunits are composed of two short
intracellular N- and C- termini, two transmembrane domains, and a large extracellular loop
(Canessa et al., 1994; Kashlan et al., 2011; Hanukoglu & Hanukoglu, 2016). In the C-terminus
of the ENaC subunits there is a highly conserved sequence named the PY (proline- tyrosine)
motif (See Fig. 1.2). The proline-rich sequence within this motif is a binding site for the
ubiquitin ligase Nedd4-2 (Neuronal precursor cells expressed developmentally down regulated
gene 4-2) (Alvarez de la Rosa et al., 2004; Lang et al., 2009; Hallows et al., 2010; Ke et al.,
2010; Chandran et al., 2011), which inhibits ENaC by ubiquitinylating the channel to promote
internalization from the plasma membrane and eventual degradation (Chen et al., 1999; Lang et
al., 2009). Interestingly, the αENaC subunit alone expressed as a homomeric channel can
produce a small, detectable Na+ current that may have a unique physiological role (Canessa et
al., 1994; Ismailov et al., 1997). Although the β and γ subunits are not able to produce a
function channel by themselves, the expression of these subunits significantly impacts the
specific channel properties including channel kinetics (Fyfe & Canessa, 1998), amiloride
sensitivity (Fyfe & Canessa, 1998), and ion selectivity (McNicholas & Canessa, 1997).
ENaC expression in the central nervous system
ENaC expression in the central nervous has become an area of increasing interest due to
the expression of the channel in several regions of the brain involved in cardiovascular control
(Amin et al., 2005). All ENaC subunits are expressed on both the basolateral and apical
membranes of the choroid plexus and ependymal cells, suggesting ENaC is involved in the
regulation of sodium concentration in cerebral spinal and brain extracellular fluids (Wang et al.,
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2010). Interestingly, abnormal regulation of sodium in the cerebral spinal fluid contributes to the
increased sympathetic activity and hypertension development in salt sensitive animal models
(Huang et al., 2008; Huang et al., 2009).

Extracellular loop

Extracellular

β

α

α

γ

Intracellular

PY

C-terminus

N-terminus

Fig. 1.2. A sketch representation of ENaC structure. ENaC is comprised of three homologous
subunits (shown in a 2α:1β:1γ ratio). Each subunit consists of two hydrophobic transmembrane
regions linked by a large, hydrophilic extracellular loop and short, cytoplasmic N-terminus and
C-terminus regions. The C-terminus contains a PY motif that includes a proline- rich region that
is important in channel retrieval from the plasma membrane and degradation.
Additionally, several studies demonstrated that central administration of amiloride, or its
analog benzamil, attenuates sympathetic activity and hypertension in several animal models of
hypertension (Gomez-Sanchez & Gomez-Sanchez, 1994, 1995; Nishimura et al., 1998; Keep et
al., 1999; Nishimura et al., 1999; Wang & Leenen, 2002; Wang et al., 2003).
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ENaC in vasopressin magnocellular neurons
In the SON and PVN, all three ENaC subunits are specifically expressed in VPsynthesizing MNCs in the SON and PVN (Teruyama et al., 2012a). Moreover, these channels
modulate the membrane potential of the neurons by mediating a Na+ leak current (Teruyama et
al., 2012a). Because the release of VP is largely regulated by the pattern and frequency of action
potentials of the synthesizing MNCs (Poulain & Wakerley, 1982), changes in the ENaCmediated current in VP MNCs could affect the central and systemic hormonal release.
Regulation of ENaC
Proteolytic processing of ENaC is also important for the regulation of ENaC activity and
surface expression (Rossier, 2004; Kleyman et al., 2006). In particular, proteolytic cleavage of
the α-and γENaC subunits releases an extracellular inhibitory domain (Passero et al., 2010) is
critical for full channel activation (Berman et al., 2015; Shobair et al., 2016). Two distinct pools
are present at the plasma membrane that consists of those that have been cleaved by proteases
and considered mature subunits or subunits that have not been cleaved and considered immature
(Hughey et al., 2003; Hughey et al., 2004b). Furin proteases, specifically, act on the extracellular
domains of the α- and γENaC subunits to produce/modify channel activity (Hughey et al.,
2004a). The physiological importance of proteolytic cleavage of ENaC is still unclear, but it has
been demonstrated that dietary salt consumption affects protease activity. For example,
proteolytic cleavage of the γENaC subunit is observed in the kidney during low sodium
consumption (Masilamani et al., 1999b; Frindt et al., 2008) and has been associated with
increased channel activity (Frindt et al., 2008). Interestingly, salt deprivation enhances the
proteolytic cleavage of the γENaC subunit in the kidney collecting tubule (Masilamani et al.,
1999a), suggesting that the cleaved form of the γENaC subunit is required for enhanced ENaC
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activity in response to physiological demand. However, more mechanistic studies will need to be
performed to elucidate the relevance of this modification.
Serum- and glucocorticoid- inducible kinase-1
Serum- and glucocorticoid- inducible kinase-1 (SGK-1) is a ubiquitously expressed
enzyme that is considered an important convergence point for multiple regulators of ENaC
expression and function (Lang et al., 2006; Burton et al., 2009; Lang et al., 2009; Salker et al.,
2011). Aldosterone binds the mineralocorticoid receptor (MR) to increase SGK-1 expression and
protein abundance (Lang et al., 2009; Fernandes-Rosa et al., 2011). Inactive SGK-1 peptides are
activated via phosphorylation by 3-phosphoinositide-dependent kinase (PDK1) (Lang et al.,
2009) and mammalian target of rapamycrin mTOR complex-2 (mTORC2), a protein kinase (Lu
et al., 2010). Activated SGK-1 peptides affect many targets, but importantly SGK-1
phosphorylates Nedd4-2 to result in inactivation of the ligase. Inactivation of Nedd4-2 by SGK-1
results in increased ENaC abundance at the cell surface (Debonneville et al., 2001). The
importance of Nedd4-2 in regulation of ENaC surface expression can be observed in patients
suffering from Liddle’s syndrome. An autosomal dominant disease, Liddle’s syndrome was first
described in 1963. Patients exhibited a significantly lower urinary Na+ excretion rate, indicative
of increased renal reabsorption (Liddle, 1963; Palmer & Alpern, 1998). A point mutation in the
proline-rich region of the βENaC subunit prevents Nedd4-2 from associating with the channel
and internalization and proteasomal degradation is prevented (Schild et al., 1996; Butterworth,
2010; Rotin & Staub, 2011; Hanukoglu & Hanukoglu, 2016). As a result, patients suffer from
early onset of severe hypertension and have an increased risk of cardiac death (Pagani et al.,
2018). Liddle’s syndrome is a severe disorder that is demonstrates the critical role of ENaC in
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maintaining a healthy homeostatic state and suggests that other hypertension and cardiovascular
disorders may involve ENaC misregulation.
Insulin regulation of ENaC
Insulin has been demonstrated to stimulate Na+ reabsorption in different portions of the
kidney including the distal collecting ducts (DeFronzo et al., 1976; Feraille et al., 1995), thick
ascending limbs (Veelken et al., 1988; Mandon et al., 1993; Ito et al., 1997), and proximal
tubules (Baum, 1987; Feraille et al., 1992; Feraille et al., 1994). Studies have demonstrated that
insulin and aldosterone have synergistic anti-natriuretic effects (Miller & Bogdonoff, 1954;
Fidelman & Watlington, 1984; Johnson et al., 1986) through regulation of ENaC mediated Na+
transport (Wang et al., 2001). Acute and chronic infusions of insulin in mice and rats,
respectively, increased the apical localization of ENaC in the distal collecting duct (Song et al.,
2006; Tiwari et al., 2007). Binding of insulin to the insulin receptor results in allosteric changes
to promote the recruitment of several adapter proteins that lead to the association of
phosphatidylinositol 3- kinase (PI3K), which phosphorylates and activate SGK1. Specifically,
insulin stimulates ENaC by increasing SGK1 activity (Mansley et al., 2016) that results in an
increased channel open probability (Marunaka et al., 1992) and increased channel density at the
cell membrane (Blazer-Yost et al., 1998).
Vasopressin regulation of ENaC
Mammalian collecting ducts exposed to vasopressin have increased ENaC activity.
Electrophysiological studies have shown that vasopressin exposure results in increased channel
open probability and the number of channels in the apical plasma membrane (Bugaj et al., 2009).
Inhibition of cAMP (cyclic adenosine monophosphate) signaling prevents the vasopressin
induced increase in ENaC activity, suggesting vasopressin via cAMP signaling promotes
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trafficking and insertion of ENaC channels into the apical membrane of principle cells of the
distal collecting duct (Ecelbarger et al., 2000; Ecelbarger et al., 2001; Nicco et al., 2001; Morris
& Schafer, 2002; Sauter et al., 2006). Vasopressin binds to V2 receptors to initiate a signaling
cascade to promote the production of cAMP to increase both ENaC and aquaporin 2 activities
(Birnbaumer et al., 1992; Lolait et al., 1992) that result in increased sodium reabsorption and
osmotic gradients, as well as increased water permeability in the collecting duct (Canessa &
Schafer, 1992; Lahr et al., 2000; Morris & Schafer, 2002; Butterworth et al., 2005; Shane et al.,
2006). It should be noted that vasopressin works in a synergistic manner with aldosterone to
increase ENaC activity (Fig. 1.3).
Tubular Lumen / apical side

+

Collecting duct
principal cells

Na
SRE
MRMR

+

K
V2
+

Aldosterone

Vasopressin

Na

Interstitial space

Fig. 1.3. A sketch representation of the synergistic effects of aldosterone and vasopressin.
Aldosterone binds to the MR to promote synthesis of ENaC subunits to generate intracellular
pools. Upon binding of vasopressin to the V2 receptor, pre-existing intracellular pools of ENaC
subunits ENaC are translocated to the apical membrane to promote Na+ reabsorption.
Animals that are deprived of water and Na+ or treated with both vasopressin and aldosterone
have the most active form of ENaC (Reif et al., 1986; Schlatter & Schafer, 1987; Bindels et al.,
1988; Chen et al., 1990; Hawk et al., 1996; Bugaj et al., 2009).
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Aldosterone regulation of ENaC
Within the epithelia, ENaC expression is primarily regulated by the main
mineralocorticoid, aldosterone, binding to the MR in a tissue specific manner (Renard et al.,
1995; Escoubet et al., 1997; Stokes & Sigmund, 1998a; Masilamani et al., 1999a; MacDonald et
al., 2000). Activation of ENaC requires expression of its regulatory proteins that are also
regulated by aldosterone and other factors (Stokes, 1999; Stockand, 2002). In taste receptor cells,
aldosterone induces γENaC expression (Lin et al., 1999) where these channels play a critical role
in transducing salt taste (Gilbertson & Kinnamon, 1996; Kinnamon & Margolskee, 1996;
Lindemann, 1996). Increases in blood aldosterone enhance the intensity of the apical
immunoreactivity for βENaC and γENaC, and increase the amplitude of amiloride-sensitive
current in taste cells (Lin et al., 1999) indicating an increased salt appetite in response to
aldosterone. Aldosterone appears to specifically induce the αENaC subunit in the kidney and
several studies have documented the effect of aldosterone on ENaC subunit expression in the
kidney (Renard et al., 1995; Asher et al., 1996; Escoubet et al., 1997; Stokes & Sigmund, 1998b;
Masilamani et al., 1999a; MacDonald et al., 2000). All of these studies have utilized different
approaches. Nonetheless, the results consistently show that aldosterone affected gene expression
of the αENaC subunit, but not γENaC or βENaC subunits in the kidney. For instance, a
deficiency in dietary NaCl intake, known to increase the circulatory level of aldosterone, caused
upregulation of αENaC in the kidney (Renard et al., 1995; Stokes & Sigmund, 1998b;
Masilamani et al., 1999a). Adrenalectomy caused a decrease in αENaC expression, while
treatment with aldosterone restored the expression (Escoubet et al., 1997; MacDonald et al.,
2000). In addition to studying the effects on kidney ENaC expression, several studies have
investigated the effects of aldosterone on colon ENaC expression. Although aldosterone
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upregulated αENaC expression at the level of the kidneys, the γENaC expression was increased
in the colon in these animals (Asher et al., 1996; Escoubet et al., 1997; Stokes & Sigmund,
1998b). Collectively, these studies reveal that aldosterone selectively influences specific ENaC
subunit expression in a cell type and/or tissue-specific manner.
Renin-angiotensin-aldosterone system
Aldosterone was first characterized in the early 1950s due to its mineralocorticoid effects
on urinary Na+/K+ ratios (Simpson et al., 1954). Synthesized from cholesterol within the zona
glomerulosa of the adrenal glands, aldosterone is released into circulation in response to changes
in blood pressure through the renin-angiotensin II-aldosterone system (RAAS), which works at
the level of the kidney to regulate sodium and water balance (Nishiyama & Kim-Mitsuyama,
2010). A decrease in blood pressure is first noted in the afferent arterioles of the kidney as a
decrease in renal perfusion that causes mechanoreceptors to release prorenin that is converted to
renin by the juxtaglomerular cells of the kidney (Sealey et al., 1977; Hackenthal et al., 1990;
Hall, 2001; Persson et al., 2004). Renin cleaves the liver-synthesized and secreted hormone
angiotensinogen to angiotensin I (Menard et al., 1983; Deschepper, 1994; Hall, 2001), which is
subsequently hydrolyzed to angiotensin II by angiotensin- converting enzyme (ACE) located in
the pulmonary and renal endothelium (Ng & Vane, 1967; Wei et al., 1991; Soubrier et al.,
1993a; Soubrier et al., 1993b; Corvol et al., 1995; Costerousse et al., 1998; Hall, 2001).
Angiotensin II binds angiotensin II type 1 and 2 receptors to have effects on the kidney, adrenal
cortex, arterial, and brain (Nishiyama et al., 2009). In the kidney, angiotensin II increases Na+/H+
exchange to promote sodium reabsorption to raise blood osmolality (Xu et al., 2006; Li & Zhuo,
2007), which results in increased blood and extracellular fluid volume and an overall increase in
arterial pressure. Angiotensin II induces vasoconstriction by binding to receptors located on
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vascular smooth muscle cells or inducing the zona glomerulosa of the adrenal cortex to stimulate
the systemic release of aldosterone (Hollenberg & Williams, 1979; Quinn & Williams, 1988;
Hall, 2001). Subsequently, aldosterone via the mineralocorticoid receptor (MR) increases sodium
reabsorption and potassium excretion at the distal tubule and collecting duct of the kidney
nephron to affect blood osmolarity by increasing expression of ENaC (Davis, 1957; Stokes &
Sigmund, 1998a; Masilamani et al., 1999b; Fuller & Young, 2005; Frindt et al., 2008; Scott &
Dunn, 2017) and Na+/K+ ATPase (Derfoul et al., 1998; Gensini et al., 2002; ChaszczewskaMarkowska et al., 2016) in the cell membrane of principle cells located in the distal tubule and
collecting ducts.
Aldosterone in the central nervous system
Unlike most steroids, circulating aldosterone has difficulty crossing the blood-brain
barrier (BBB) (Pardridge & Mietus, 1979a, b; Pardridge, 1981; Funder & Myles, 1996; Parker et
al., 2006). It is known, however, that a small amount of aldosterone is synthesized in the brain
independently of the adrenal cortex. The transcripts of aldosterone synthase (CYP11B2), an
enzyme that converts 11-deoxycorticosterone to aldosterone, has been detected in several brain
regions including the rat hypothalamus (MacKenzie et al., 2000). The capability of the brain
tissue to synthesize aldosterone was also demonstrated in vitro (Gomez-Sanchez et al., 2005a).
Moreover, a recent study used in situ hybridization to detect the presence of aldosterone synthase
in magnocellular neurons in the SON (Wang et al., 2016).
Aldosterone regulation of ENaC in the central nervous system
Several studies suggest the ENaCs in the brain are also regulated by aldosterone.
Administration of aldosterone in the rat brain increases blood pressure (Gomez-Sanchez et al.,
1992; Wang & Leenen, 2002; Wang et al., 2003). Importantly, this effect was attenuated by
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central administration of the ENaC inhibitor, benzamil (Gomez-Sanchez & Gomez-Sanchez,
1995; Nishimura et al., 1998), suggesting that aldosterone-regulated benzamil-sensitive
structure(s) in the brain are involved in the regulation of blood pressure. Intracerebroventricular
(ICV) infusion of the aldosterone synthase inhibitor, FAD286, prevented the increase in both
hypothalamic aldosterone and blood pressure associated with high dietary salt intake in Dahl salt
sensitive rats (Huang et al., 2008). Chronic subcutaneous aldosterone infusion for 10 days was
found to increase γENaC mRNA level in the subfornical organ (SFO) of the hypothalamus in rats
that were provided with saline drinking fluid (aldosterone salt-induced hypertension model)
(Wang et al., 2016). Although the SFO is a structure in the brain, it is known that it lacks the
BBB and shows high expression of MR (Amin et al., 2005). Therefore, aldosterone from
subcutaneous infusion may directly affect the expression of γENaC in the SFO. Although several
lines of evidence suggest that aldosterone is synthesized locally in the hypothalamus by MNCs
(Wang et al., 2016), the physiological conditions and mechanisms that induce aldosterone
synthesis in the hypothalamus are still largely unknown.
Glucocorticoid regulation of ENaC
Glucocorticoid induction of ENaC subunit expression is well documented in different cell
types and organs. Glucocorticoid, but not aldosterone, was found to induce the expression of all
ENaC subunits (Champigny et al., 1994; Renard et al., 1995). Subcutaneous infusion of either
aldosterone or the glucocorticoid receptor (GR) agonist, dexamethasone, for three days induced
αENaC expression in the kidney, whereas this treatment resulted in the induction of βENaC and
γENaC expression in the distal colon of the same animals (Asher et al., 1996). In addition,
studies have shown that the functional properties of the glucocorticoid-MR complexes are
different from those of aldosterone-MR complexes (Lombes et al., 1994; Kitagawa et al., 2002).
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Glucocorticoids and mineralocorticoids have different effects on ENaC activity in the kidney
(Frindt & Palmer, 2012). Infusion of the synthetic glucocorticoid, dexamethasone, resulted in an
increase in the abundance of αENaC in the rat kidney. However, this response was not
accompanied by an induction of amiloride-sensitive Na+ currents, an increase in the abundance
of the cleaved (active) forms of either αENaC or γENaC, or the expression of βENaC or γENaC
protein at the cell surface (Frindt & Palmer, 2012). It is possible that the GR- corticosterone
complex does not affect expression of some of the ENaC regulatory proteins to induce full
channel activation. Further experiments are needed to clearly define the specific pathway
involving glucocorticoid regulation of ENaC and how it differs from mineralocorticoid
regulation.
Mineralocorticoid and glucocorticoid receptors
Both the MR and GR belong to the nuclear receptor superfamily and act as ligandinduced transcription factors to regulate gene expression (Vallon et al., 2005; Ronzaud et al.,
2007; Ackermann et al., 2010). MR has three known ligands: aldosterone, cortisol, and
progesterone (Myles & Funder, 1996; Quinkler et al., 2004). Additionally, corticosterone binds
to the GR and MR with similar affinity (Beaumont & Fanestil, 1983; Krozowski & Funder,
1983; Reul & de Kloet, 1985; Sheppard & Funder, 1987a; Sheppard & Funder, 1987b; Funder,
1995). Upon hormone binding in the cytosol, MR forms homodimers and heterodimers with GR
and is translocated into the nucleus where it binds to the hormone-responsive element of the
target gene (Ou et al., 2001; Gekle et al., 2014). Since the DNA binding domains of the MR and
GR share approximately 94% amino acid homology (Viengchareun et al., 2007), both the MR
and GR are thought to bind common hormone-responsive elements in a sequence-specific
manner to regulate some of the same genes (Evans & Arriza, 1989). It is known that activation of
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MR requires coactivators and some of the MR coactivators appear to be ligand-specific, such as
the coactivation of the MR that occurs in the presence of aldosterone, but not of cortisol
(Kitagawa et al., 2002).
11β-hydryoxysteriod dehydrogenase type 2
Although the plasma concentrations of glucocorticoids are substantially higher than those
of aldosterone (Holbrook et al., 1980), aldosterone is known to preferentially bind to MR in
aldosterone sensitive-epithelia (Odermatt et al., 2001). Aldosterone selectivity of the MR in the
epithelia is achieved by inactivating intracellular glucocorticoids through the glucocorticoidinactivating enzyme, 11β–hydroxysteriod dehydrogenase type 2 (11β-HSD2) (Gomez-Sanchez et
al., 2005b), which converts corticosterone into inactive metabolites (Funder, 1995; Naray-FejesToth et al., 1998). Experiments with HEK-293 cultured cells expressing recombinant MR and
11β-HSD2 showed that11β-HSD2 is associated with the MR at the endoplasmic reticulum
membrane and prevents cortisol activation of MR (Odermatt et al., 2001).
Rationale for the current studies
Previous studies have investigated the role of the ENaC in vasopressin-synthesizing
neurons and found that ENaC contributes to the resting membrane potential in these neurons
(Teruyama et al., 2012b). Additionally, it was previously demonstrated that normotensive
animals fed high salt diet had an increase in γENaC expression and associated enhanced ENaC
activity in VP neurons (Sharma et al., 2017). The regulatory mechanism of ENaC expression in
these neurons remains unknown. Studies conducted in Chapter 2 sought to elucidate the
regulatory mechanism involved in vasopressin-synthesizing neurons with regard to ENaC
expression. Overall, results from this study demonstrated aldosterone-binding to the MR results
in increased γENaC expression and abundance. It was also previously shown that Dahl-SS rats,
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an established animal model of salt–sensitivity, have elevated central aldosterone synthesis
(Gomez-Sanchez & Gomez-Sanchez, 1995) and elevated aldosterone levels contributes to saltsensitive hypertension development (Huang et al., 2009; Gomez-Sanchez et al., 2010). However,
the effect of high dietary salt intake on central ENaC expression has not been examined during
times of salt-sensitivity. Studies conducted in Chapter 3 sought to determine the effect of dietary
salt on hypothalamic and kidney ENaC expression in Dahl-SS rats and normotensive SpragueDawley rats. Results from this study suggest that animals with salt-sensitivity lack a
compensatory mechanism that is present in normotensive animals to prevent hypertension
development.
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CHAPTER 2
ALDOSTERONE MEDIATED REGULATION OF EPITHELIAL SODIUM
CHANNEL (ENAC) IN THE RAT HYPOTHALAMUS
Introduction
Vasopressin (VP) is synthesized in magnocellular neurons located in both the
paraventricular (PVN) and the supraoptic (SON) nuclei of the hypothalamus and is released from
the neurohypophysis into the general circulation. VP neurons increase VP secretion in response
to hyperosmolality (Brimble & Dyball, 1977), hypovolemia (Harris et al., 1975) and hypotension
(Khanna et al., 1994) to produce antidiuretic and pressor effects. The release of VP also occurs
from the soma and dendrites of VP neurons in the PVN to increase the activity of parvocellular
neurons within the PVN that project to the rostral ventrolateral medulla (Son & Stern, 2011).
This action affects sympathetic outflow and blood pressure (Dampney, 1994). VP neurons thus
play a pivotal role in coordinating neuroendocrine and autonomic responses to maintain
cardiovascular homeostasis. Because the release of VP depends largely on the pattern of
neuronal activity of the synthesizing neurons (Poulain & Wakerley, 1982; Cazalis et al., 1985),
factors modulating neuronal activity of VP neurons are of great interest.
The non-voltage dependent and amiloride-sensitive epithelial Na+ channel (ENaC) is a
member of the degenerin/epithelial sodium channel (Deg/ENaC) superfamily and is composed of
three subunits (α, β, and γ) that form a highly selective Na+ channel (Canessa et al., 1994).
ENaC is present in aldosterone-sensitive epithelia that are responsible for trans-epithelial Na+
transport, such as in epithelial cells that line the distal part of the renal tubule, the distal colon,
the duct of several exocrine glands, and the lung. ENaC expression was also demonstrated in
various structures in the brain, namely the SON, PVN, subfornical organ, choroid plexus, and
ependyma of the anterovental third ventricle (Amin et al., 2005). Although the functions of
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ENaC in the brain are still largely unknown, several studies showed that central administration of
the ENaC blocker, amiloride or its analog benzamil, attenuates sympathetic activity and
hypertension in several animal models of hypertension (Gomez-Sanchez & Gomez-Sanchez,
1994, 1995; Nishimura et al., 1998; Keep et al., 1999; Nishimura et al., 1999; Wang & Leenen,
2002; Wang et al., 2003) and heart-failure (Ito et al., 2015), indicating that abnormally regulated
ENaC in the brain plays a significant role in the development of hypertension.
Our previous study (Teruyama et al., 2012b) demonstrated that ENaC is specifically
expressed in VP neurons and modulates the membrane potential by mediating a Na+ leak current.
In addition, our recent study showed that animals that consumed high dietary salt displayed an
enhanced ENaC current, which resulted in further depolarization of the basal membrane potential
of VP neurons (Sharma et al., 2017). These findings indicate that high dietary salt intake
enhances the expression and activity of ENaC, which in turn, augments synaptic drive during
hormonal demand by depolarizing the basal membrane potential closer to the action potential
threshold. Activation of ENaC, therefore, is a powerful means to modulate hormone secretion
according to physiological demands. Furthermore, considering the role of VP in the
cardiovascular homeostasis, ENaC in VP neurons may have a major role in the regulation of
blood pressure. However, the mechanism underlying the regulation of ENaC activity in VP
neurons remains mostly unknown.
ENaC expression in epithelia is primarily regulated by the mineralocorticoid, aldosterone,
via the mineralocorticoid receptor (MR) (Renard et al., 1995; Escoubet et al., 1997; Stokes &
Sigmund, 1998a; Masilamani et al., 1999; MacDonald et al., 2000). Because the MR and ENaC
are co-localized in VP neurons in the SON and PVN (Teruyama et al., 2012a; Haque et al.,
2015), ENaC in VP neurons are likely regulated by aldosterone. The present study using acutely
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prepared hypothalamic slices incubated with aldosterone was conducted to examine the effects of
aldosterone on the expression and activity of ENaC in VP neurons. This in vitro approach
allowed us to evaluate the effect of aldosterone on ENaC in VP neurons more directly without
the context of whole animal physiology.
Methods
Animals
Male Wistar rats (Harlan Laboratories, Indianapolis, IN) weighing between 260-300g
were used in the present investigation. Rats were housed on a 12:12-h light-dark cycle and were
allowed standard chow and water ad libitum. All protocols were carried out in accordance
with the National Institute of health Guide for the Care and Use of Laboratory animals and
were approved by the Institutional Animal Care and Use Committees of Louisiana State
University.
Acute hypothalamic slice preparation
Rats were deeply anaesthetized with Ketamine-Xylazine (9:1, 100 mg/kg i.p.) and
perfused through the heart with cold artificial cerebral spinal fluid (aCSF), in which NaCl was
replaced by equiosmolar sucrose containing (in mM: 210 Sucrose, 3 KCl, 2.0 CaCl2, 1.3 MgCl2,
1.24 NaH2PO4, 25 NaHCO3, 0.2 ascorbic acid, and 10 D-glucose; pH 7.4). The brain of each rat
was removed and three coronal slices (500 µm), containing the entirety of the SON and PVN,
were collected using a vibrating microtome (Leica VT1200; Leica, Mannheim, Germany). Other
brain areas that are known to express ENaC, namely the vascular organ of lamina terminalis
(OVLT) (Miller & Loewy, 2013), area postrema (Miller et al., 2013), and subfornical organ
(SFO) (Wang et al., 2016), were not included. Slices were divided into two equal halves along
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the midline at the third ventricle using microdissection scissors. Slice halves from the right side
were placed in the control group, while the left halves were placed in the treatment group.
In vitro incubation with corticosteroids
The hypothalamic slices were incubated on a plastic tray that consisted of wells with
nylon mesh bottoms to hold individual slices in a glass beaker that was filled with 200 ml
artificial cerebral spinal fluid (aCSF) (in mM: 125 NaCl, 3 KCl, 2.0 CaCl2, 1.3 MgCl2,
1.24 NaH2PO4, 25 NaHCO3, 0.2 ascorbic acid, and 10 D-glucose; pH 7.4) with normal
physiological osmolality (~295 mOsm/kg). The normal physiological osmolality of aCSF was
chosen to avoid possible effects of higher osmolality on ENaC expression, since
intracerebroventricular (ICV) infusion of Na+-rich aCSF caused an increase in hypothalamic
aldosterone concentration in rats (Huang et al., 2008) and vasopressin neurons are directly
osmosensitive (Oliet & Bourque, 1993). The slices were continuously oxygenated with 95% O2/
5% CO2 gas and maintained at 34°C. The incubation trays were placed at approximately half the
depth of the beaker to ensure that the slices were completely immersed throughout the
experiment. Slices were incubated for 6 hr with aldosterone, corticosterone, or vehicle. An
incubation time of 6 hr was chosen because a pilot study showed 6 hr is the minimum duration
that produced significant changes in the amount of γENaC mRNA. In addition, a longer
incubation time did not allow us to conduct several-hour-long electrophysiological experiments
before the brain slices started to deteriorate. In some experiments, slices were preincubated for
30 min with the antagonist for the MR or glucocorticoid receptor (GR) to block MR and GR
prior to aldosterone or corticosterone application, respectively. Following incubation, slices were
trimmed along the dorsal portion of the third ventricle lateral to the optic chiasm to minimize
tissue that did not contain the PVN and SON and to exclude the choroid plexus that is known to
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express ENaC subunits (Amin et al., 2005). Trimmed slices were placed in RNALater (Qiagen,
Germantown, MD) and stored at -20°C for later processing. Additional hypothalamic slices were
fixed in 4% paraformaldehyde with 0.1% picric acid in 0.15 M sodium phosphate buffer (pH 7.27.4) and processed for immunocytochemistry.
Corticosteroids and antagonists
Aldosterone and corticosterone were purchased from Sigma-Aldrich (St. Louis, MO).
Antagonists for MR and glucocorticoid receptors (GR) were RU-28318 (Tocris Bioscience,
Ellisville, MO) and RU-486 (Sigma- Aldrich, St. Louis, MO), respectively. All compounds were
dissolved into dimethyl sulfoxide (DMSO) to make stock solutions and were further diluted in
aCSF to reach the final concentration. The concentration of aldosterone, corticosterone, and RU28318 used for incubations was 2.5 µM and RU-486 was 5 µM. The final concentration of
DMSO in aCSF was 0.05% when aldosterone or corticosterone was applied and 0.1% when MR
or GR antagonists were applied in addition to aldosterone or corticosterone.
Real-time PCR
Total RNA was isolated using TriReagent (Sigma-Aldrich, St Louis, MO) according to
the manufacture’s instructions, and tissue was homogenized using a tissue lyser (Qiagen,
Valencia, CA). Lysate was then treated with chloroform (ThermoFisher Scientific, Waltham,
MA) and centrifuged at 12,000 rpm for 15 min. Total RNA was precipitated from the aqueous
stage using isopropyl alcohol, and then washed with ethanol. Precipitate was suspended in 20 µl
RNAase-free water. The concentration and quality of the isolated RNA were assessed using a
spectrophotometer (NanoDrop 1000, ThermoFisher Scientific, Waltham, MA). Isolated mRNA
was reverse transcribed to cDNA using oligo dT and M-MLV reverse transcriptase (SigmaAldrich, St. Luis, MO) and used in real-time RT-PCR analysis. The ABI ViiA-7 sequence
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detection system (ABI Applied Biosystem, Grand Island, NY) was used in conjunction with the
SYBR Select Master Mix (ABI Applied Biosystem, Grand Island, NY). All samples were
measured in triplicate and the two closest cycle threshold (Ct) values were averaged for each
sample.
The effects of the treatments were examined via the relative changes of the specific target
genes, which were calculated using the comparative cycle threshold method. For each sample,
the average Ct value of the target gene was subtracted by the housekeeping (Cyclophilin B) gene
to obtain the ΔCt value. The ΔCt values of the designated control group were averaged and
subtracted from each sample to generate the ΔΔCt value. Relative change was then calculated for
each sample by using the formula 2 - Δ ΔCt. All results are shown as relative change in comparison
to the control. The Student's t test was used for comparison between treatment groups.
Differences were considered to be statistically significant at p <0.05.
Primers of selected genes were designed using Primer 3 software (Whitehead Institute for
Biomedical Research) and purchased from Sigma-Aldrich (St. Louis, MO). All primer sequences
were blasted on the National Center for Biotechnology Information database to determine
specificity of targeted gene. The sequences of the primer used are listed in Table 1.
Semiquantitative immunoblotting
Total protein lysate samples were collected from above mentioned hypothalamic slice
preparation. The hypothalamic slices were incubated for 6 hr with 2.5 µM aldosterone or vehicle,
and were rinsed with cold PBS and placed in microcentrifuge tubes containing 250 µl of chilled
complete lysis buffer. Lysis buffer was made fresh before each experiment. Complete buffer
contained: RIPA buffer (50 mM NaCl, 1.0% IGEPAL® CA-630, 0.5% sodium deoxycholate,
0.1% SDS, 50 mM Tris, pH 8.0; Sigma-Aldrich, St. Louis, MO), protease inhibitors
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(ProteoGuardTM EDTA-free protease inhibitor cocktail; Takara Clontech, Mountain View, CA),
1 mM EGTA, 1 mM EDTA, and 1mM DTT. Samples were briefly homogenized utilizing an
electric tissue lyser (Qiagen, Valencia, CA) and allowed to stand on ice for 10 min. Lysed
samples were centrifuged for 20 min at 12,000 rpm at 4°C. The pellet was discarded and the
clear supernatant (total lysate) was transferred to a clean tube to be stored at -20°C for later
processing.
After protein concentration was determined (BCA kit; Pierce Chemical Co., Rockford,
Illinois, USA), samples (15-20 µg of protein) were denatured by heating in 1x Laemmli buffer
(Bio-Rad) for 5 min at 95°C. Samples were resolved in a 4-15% SDS-PAGE (Mini PROTEAN
Precast Gels, Bio-Rad) gradient gel in Tris-glycine buffer (25 mM, 192 mM glycine, 0.1% SDS,
pH 8.3; Bio-Rad) and transferred to a PVDF membrane (Bio-Rad, Hercules, CA) under wet
conditions (50V for 2 hr at 4°C). To determine a successful transfer, the membrane was stained
with Ponceau S solution (Sigm-Aldrich, St. Louis, MO) for approximately 1 min. The membrane
was destained with 0.1 M NaOH for 30 sec followed by quick TBST wash (TBS-Tween; 50 mM
Tris base, 200 mM NaCl, 0.05% Tween 20). The membrane was blocked with 5% non-fat buffer
(NFM; Bio-Rad, Hercules, CA) for 1 hr at room temp, and incubated overnight at 4°C with the
selected primary antibody dissolved in 5% NFM buffer. A final concentration for all ENaC
primary antibodies was 1 µg/ml. Glyceraldehydye 3- phosphate dehydrogenase (GAPDH;
Abcam, Cambridge, MA) primary antibody was used as a load control with a final concentration
of 0.125 µg/ml. The next day, the membrane was washed three times for 10 min each with TBST
and incubated with the horseradish peroxidase- conjugated (HRP) secondary antibody against the
respective host species (1:10,000, Goat- anti Rabbit – HRP; 1:10;000, Goat- anti Mouse, BioRad) dissolved in 5% NFM buffer at room temp for 2 hr followed by six TBST washes for 10
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min each. Protein bands were detected through chemiluminescence reagents (ClarityTM Western
ECl Substrate Kit; Bio-Rad, Hercules, CA) and imaged utilizing a gel imaging system
(ChemiDocTM XRS+; Bio-Rad, Hercules, CA). Densitometric measurements were obtained
through ImageJ (NIH, Bethesda, MD).
Chromatin Immunoprecipitation (ChIP) and qPCR analyses
The rats (n=19) were deeply anesthetized with Ketamine:Xylazine (9:1; 100 mg/kg; i.p.)
and transcardially perfused with an artificial cerebrospinal fluid (aCSF) in which NaCl was
replaced by equiosmolar sucrose (in mM: 210 Sucrose, 3 KCl, 2 CaCl2, 1.3 MgCl2, 1.24
NaH2PO4, 25 NaHCO3, 0.2 ascorbic acid, and 10 D-glucose; pH 7.4). The brains were removed
and a hypothalamic block (4.5mm: 0.4gm) containing the SON and PVN was made. Kidneys
were also removed and blocked to be of equal weight as the brain. The blocked tissues were
ground and homogenized in 2 ml sodium phosphate buffered saline (PBS; pH 7.2) containing 20
µl protease inhibitor (635673, Clontech, Mountain View, CA). The homogenized samples were
first cross-linked with 1% formaldehyde for 20 min at 37 ºC, and then lysed in SDS lysis buffer
(1% SDS, 10mM EDTA, 50mM Tris-HCl; pH 8.1) containing a protease inhibitor. The released
nuclei were fractioned with sonication to obtain a pool of DNA fragments of 300 to 500 bp in
length. The sonicated samples were divided into 3 individual aliquots. 60 µl of the protein A/G
plus agarose beads (sc-2003, Santa Cruz Biotechnology, Dallas, TX) were added to two tubes
and incubated for 2 hr at 4 ºC with gentle agitation to preclear the lysates. One tube containing
the lysate was used as the input control. The samples were centrifuged at 2,000 rpm at 4 ºC for 5
min, and one of the two subsequent supernatants was used for immunoprecipitation. Four
different anti-MR monoclonal antibodies (rMR1-18 1D5, MRN2 2B7, MRN3 3F10, and
rMR365 4D6) were obtained from the Developmental Studies Hybridoma Bank (Iowa City, IA).
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The supernatants were incubated with a cocktail of the anti-MR antibodies at equal ratio (2.5 µg)
for overnight at 4 ºC with gentle agitation. After incubation with the antibodies, 120 µl of the
protein A/G agarose beads were added to both tubes (with Ab and without Ab) and incubated
overnight at 4 ºC. Subsequently, the samples were centrifuged at 1,000 rpm at 4 ºC for 5 min to
remove the supernatants and the remaining beads were washed five times in wash buffers. The
proteins were eluted using an elution buffer containing 1% SDS and 0.1M NaHCO3. The proteinDNA crosslinks were reversed by heating at 65 ºC overnight with gentle agitation. The DNA was
recovered by phenol/chloroform extraction, precipitated with ethanol, and dissolved in 25 µl TE
buffer (pH 8.0). Input control, Ab, and no Ab samples (2 µl each) were subjected to PCR with
JumpStart REDTaq DNA polymerase (D0563, Sigma- Aldrich, St. Louis, MO) to detect the MRbinding sites in the promoter region in Scnn1g. The primer set (Forward 5’GAAGGGTGAGATGGATTGGA- 3’ and Reverse 5’- GTAGGGGAAAGGGGGTAACA- 3’,
chr1:191706400-191706675, 276 bp) was specifically designed based on a previous study
(Lombès et al., 1993). The following PCR conditions were used: 95 ºC for 90 sec, 45 repetitions
of the following cycles 95 ºC for 30 sec, 60 ºC for 10 sec, 72 ºC for 60 sec, and final extension at
72 ºC for 5 min. The PCR products from the input DNA, negative control (no Ab) and MR ChIP
were separated by agarose gel electrophoresis and visualized with ethidium bromide. For
quantitative PCR (qPCR) analysis, the total DNA concentrations of the samples were measured
using Nanodrop 2000 (Thermo Fisher Scientific, Waltham, MA) and normalized so that equal
amounts of DNA were amplified. The normalized product (2 µl) was used for PCR with SYBR
Select Master Mix (4472897, ABI Applied Biosystems, Foster City, CA). The following PCR
conditions were used: 95 ͦ C for 90 sec, 40 repetitions of the following cycles 95 ͦ C for 30 sec,
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60 ͦ C for 60 sec, and final extension at 72 ͦ C for 5 min. Results are reported as a percent change
compared to the input control.
Immunocytochemistry
Hypothalamic slices from six animals were processed concurrently under the same
conditions for immunocytochemical localization of ENaC subunits. The 500 µm thick
hypothalamic slices were cryoprotected by immersing in 50% glycerol in PBS for ~5 min before
mounting on a freezing microtome (SM2010R; Leica, Mannheim, Germany) and sectioned at 40
µm. Slices were incubated with 5% normal goat serum in PBS containing 0.5% Triton X-100
(PBST) for 30 min at room temperature followed by the primary antibodies directed against
αENaC, βENaC, or γENaC at dilutions of 1:2,000, 1:500, and 1:4,000, respectively at 4°C with
continuous gentle agitation for overnight. The rabbit antibodies against the ENaC subunits were
a generous gift from Dr. Mark A. Knepper (National Institutes of Health, Bethesda, MD), and the
characterizations of these antibodies were previously described in great detail (Masilamani et al.,
1999). The hypothalamic slices were incubated with biotinylated goat-anti-rabbit IgG (1:500 in
PBST; Vector, Burlingame, CA) for 2 hr and with ABC complex (1:500 in PBST, Vector,
Burlingame, CA) for 1 hr. Subsequently, slices were incubated with diaminobenzidine (DAB;
Vector, Burlingame, CA) to visualize the immunoreactivity. Slices were washed in PBST (3x5
min each) between each step. Finally, slices were mounted on subbed slides, air-dried overnight,
dehydrated in a series of alcohols, cleared in xylene, and coverslipped with Permount (Fisher
Scientific, Waltham, MA) mounting medium. The hypothalamic slices containing the SON and
PVN were digitally photomicrographed in 12-bit intensity levels using a microscope (Nikon
Eclipse 80i, Tokyo, Japan) equipped with a digital camera (Nikon DS-QiMc, Tokyo, Japan).
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For fluorescent confocal microscopy, the brain slices were incubated with a secondary
antibody (goat anti-rabbit) conjugated with DyLight 594 (Jackson ImmunoResearch, West
Grove, PA) for 4 hr at room temperature. The hypothalamic slices were examined with a
confocal microscope (Leica TCS SP8, Mannheim, Germany) using a 63X/1.4 n.a. oil immersion
objective lens. Confocal z-stacks (1024x1024; 0.232 µm/pixel) were acquired at the optical
section thickness of 1 µm.
Electrophysiology
Brain slices were obtained as described in Acute hypothalamic slice preparation and
incubated with aldosterone or vehicle for 6 hr prior to the electrophysiological experiments.
Whole-cell currents were recorded digitally at 20 kHz and filtered at 5 kHz with a Digidata
1440A and an Axopatch 700B (Molecular Devices, Foster City, CA) amplifier in conjunction
with PClamp 10 software (Molecular Devices, Foster City, CA). Magnocellular neurons in the
SON were visually identified with a microscope (Olympus BX50WI, Tokyo, Japan) equipped
with a 40x water immersion lens (0.8 n.a., Olympus, Tokyo, Japan). Recordings were taken
using borosilicate electrodes (4-8MΩ resistance) produced with a horizontal electrode puller
(Model P-1000 Micropipette puller, Sutter Instruments, Novato, CA). The patch solution
contained (in mM): 140 K-Gluconate, 1 MgCl2, 10 HEPES, 10 CaCl2, 2 ATP (Mg2+), and 0.4
GTP (Na+), and 11 EGTA. The patch solutions also contained 0.2% biocytin (Sigma- Aldrich,
St. Louis, MO) to identify the cell type of the patched cell (Teruyama & Armstrong, 2005,
2007). The medium was saturated with 95% O2/5% CO2 and was warmed to 33-34°C during the
recordings. ACSF contained picrotoxin and DNQX (100 and 10 µM, respectively) to suppress
the synaptic activity. The ENaC current was estimated from the benzamil-sensitive current that
was obtained from the difference in the steady state currents before and after the application of
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benzamil (2 µM). Amiloride and its derivative benzamil are known potent blockers of the
degenerin/epithelial sodium channel superfamily of ion channels and the Na+/H+ exchanger
(NHE) and the Na+/Ca2+ exchanger (NCX); however, benzamil at the dosage used in this study
(2 µM) is reasonably specific for ENaC as compared to the NHE and NCX (Kleyman & Cragoe,
1988).
Statistics
Real-time PCR data were analyzed with the Student's t test for comparison between
treatment groups and control. For semi-quantitative immunoblotting, densitometric
measurements of bands were analyzed as comparison between control and aldosterone values for
individual animals. Differences were considered to be statistically significant at p <0.05. Boxand-Whisker plot were used to represent numerical data: the mean and median are represented by
an open circle and a line, respectively; the box extends to the quartiles of data points; the
whiskers extend to the farthest data points.
Results
Dose-response relationship of aldosterone and ENaC subunit expression
The dose-response relationships of aldosterone and ENaC subunit gene expression were
assessed by changes in the relative amount of mRNA for each of the subunits in response to
incubation for 6 hr with aldosterone at concentration of 0.1 (n=6), 0.5 (n=15), 2.5 (n=12), and
12.5 (n=6) µM. The expression of αENaC and βENaC did not change significantly in response
to aldosterone at any concentration tested; however, the expression of γENaC was significantly
higher on the side of hypothalamus that was incubated with aldosterone at 2.5 (p = 0.003) and
12.5 (p = 0.038) µM compared to the side of the hypothalamus incubated with vehicle only.
When the responses were plotted against log concentration of aldosterone, only the expression of
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γENaC showed a graded dose-response (Fig. 2.1). Because the minimum concentration of
aldosterone required to induce a significant level of γENaC expression within 6 hr was 2.5 µM,
subsequent experiments were conducted using 2.5 µM aldosterone.

Fig. 2.1. Dose-response relationship of aldosterone and the expression of ENaC subunits. Semilog plots of changes in the relative amount of ENaC subunit mRNA in response to different
concentrations of aldosterone. The expression of αENaC and βENaC did not change
significantly at any concentration tested; however, the expression of γENaC was significantly
higher on the side of hypothalamus that were incubated with aldosterone at 2.5 µM
concentration compared to the side of the hypothalamus incubated with vehicle only.
Aldosterone induces γENaC expression via the MR in the hypothalamus
The effects of aldosterone on the expression of α-, β-, and γENaC subunits in the
hypothalamus was assessed by changes in the relative amount of mRNA for each of the subunits
(See Fig. 2.2). A significantly higher expression of γENaC was observed on the side of the
hypothalamic slice that was incubated with aldosterone compared to the side incubated with
vehicle only (Fig. 2.2A). In contrast to γENaC mRNA, no detectable effects of aldosterone on
the amount of αENaC or βENaC mRNAs were observed. To determine if the effect of
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aldosterone on the expression γENaC was mediated by the MR, one side of each hypothalamic
slice was treated with a selective MR antagonist, RU-28318, prior to the application of
aldosterone. The relative amount of γENaC mRNA was significantly lower on the side of the
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Fig. 2.2. The effect of aldosterone on ENaC subunit expression in hypothalamic slices. A. No
significant difference in the relative amounts of αENaC and βENaC subunit mRNAs was
identified between the aldosterone incubated and control side of hypothalamic slices; however,
only the aldosterone incubated side had a significantly greater amount of γENaC subunit mRNA
(*p<0.003). B. No significant differences in αENaC and βENaC subunit expression occurred
between the sides of the hypothalamic slices that were pre-incubated with and without RU28318, respectively; however, the side of the hypothalamic slices that was not pre-incubated with
RU-28318 had a significantly higher γENaC subunit expression compared to the side preincubated with MR antagonist, RU-28318 (**p<0.034). C. No significant differences in αENaC,
βENaC, or γENaC subunit expression observed between the sides of the hypothalamic slices that
were incubated with and without RU-28318.
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hypothalamic slices pretreated with the MR antagonist compared to the aldosterone-only treated
side suggesting that the MR antagonist prevented the aldosterone induced γENaC expression
(Fig. 2.2B). There were no detectable differences in the relative amounts of αENaC and βENaC
subunit mRNAs between the RU28318 pretreated and non-treated groups (Fig. 2.2B). In
addition, the treatment with RU28318 alone did not affect the relative amounts of αENaC,
βENaC, or γENaC subunit mRNAs (Fig. 2.2C).
Semi-quantitative immunoblotting was also performed to assess whether the abundance
of ENaC subunit proteins changed in response to aldosterone. Distinct bands at the predicted
molecular weights of 87 kDa and 85 kDa in protein extract from the hypothalamus were detected
by αENaC and γENaC antibodies, respectively (Fig. 2.43A). No detectable band was labeled by
the βENaC antibody in the protein extracted from the hypothalamus (Fig. 2.3A), although a band
at the predicted molecular weight of 88 kDa was labeled by the βENaC antibody in the protein
extract from the kidney cortex (data not shown). The abundance of γENaC protein increased
significantly on the side of hypothalamic slice that was incubated with aldosterone; however, the
abundance of αENaC protein was unchanged (Fig. 2.3B).
Furthermore, Chromatin Immunoprecipitation (ChIP) was performed to assess
whether the aldosterone-MR complex directly binds to the promoter region of the γENaC gene
(Scnn1g). MR antibodies were used to precipitate fractions of DNA containing the MR. Realtime PCR with a specific primer set detected the promoter region of Scnn1g in the MRimmunoprecipitated DNA fractions (Fig. 2.4). Results from this experiment indicate that the MR
binds directly to the promoter region of the γENaC DNA, and suggests that binding of the MRaldosterone complex directly promotes γENaC expression in VP neurons in the hypothalamus.
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Fig. 2.3. The effect of aldosterone on ENaC subunit proteins abundance in hypothalamic slices.
A. Immunoblots showing the effect of aldosterone on the abundance and molecular weight of
each ENaC subunit in the hypothalamic slices from 7 different animals. For each blot, each lane
was loaded with the protein extract from a side of hypothalamic slices from an individual animal.
The first seven lanes represent the side of the hypothalamic slice that were treated only with
vehicle, whereas the following seven lanes represent side of slices that were treated with
aldosterone. Antibodies against αENaC, γENaC, and GAPDH detected a single band at the
correct molecular mass at approximately 87, 85, and 37 kDa, respectivelyB. Densitometric
measurements of each band of αENaC and γENaC immunoblot from the side of
hypothalamic slice that were treated with aldosterone and the other side of hypothalamic
slices that were treated with vehicle only. Data points from same animal are connected by a
line. The treatment with aldosterone resulted in no change in the band density of αENaC
immunoblot; however, treatment caused a significant increase in the density of γENaC
immunoblot.
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Fig. 2.4. Chromatin Immunoprecipitation (ChIP) with MR antibody. A. Schematic representation
of the genomic structure of Scnn1-g and the relative position of the primer set used for ChIP
experiments. The 13 exons of Scnn1-g are indicated with vertical lines and boxes. B. MR-ChIP
experiments using chromatins prepared from rat brain and kidney. The DNA from input
controls, immunoprecipitates with anti-MR antibody (Ab+), and negative controls (Ab-) were
used for PCR amplification. C. The reduced level of Ab- expression and similar expression of
Ab+ in comparison to input control was further analyzed with qPCR. Shown are the relative
amount of immunoprecipitated DNA and negative control compared to those from input control.
Experiments performed by: K. Sharma
Corticosterone induces γENaC expression through the GR in the hypothalamus
The effect of corticosterone on the expressions of the α, β, and γ ENaC subunits in the
hypothalamus was also assessed by determining the relative amount of mRNA for each of the
subunits. Incubation with corticosterone caused a significantly higher γENaC subunit expression
in the hypothalamic slice; however, no detectable effects were observed in the expression of the
αENaC and βENaC subunits (Fig. 2.5A).
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Because the MR has a similar binding affinity for both mineralocorticoids and
glucocorticoids (Funder, 1995), experiments were performed to determine if the MR mediated
the effect of corticosterone on γENaC expression. One side of the hypothalamic slices was pretreated with the MR-antagonist, RU-28318, prior to the application of corticosterone, while the
other side was treated with corticosterone only. No significant difference was detected in the
relative amounts of mRNAs for all ENaC subunits between the corticosterone-only treated side
of the hypothalamic slices and those treated with the MR antagonist and corticosterone (Fig.
2.5B), indicating pretreatment with RU-28318 failed to block an increase in γENaC mRNA by
corticosterone in hypothalamic slices.
Because the MR antagonist was unable to attenuate the effects of corticosterone on
γENaC expression, it was likely that corticosterone bound to the GR to induce γENaC expression
in the hypothalamus. To test this hypothesis, one side of the hypothalamic slices was pre-treated
with RU-486, a selective GR antagonist, prior to the application of corticosterone, while the
other side was treated with corticosterone only. The relative amount of γENaC mRNA was
significantly lower on the side of hypothalamic slices treated with RU486 compared to those
treated with corticosterone only; also, there were no detectable differences in αENaC or βENaC
expression between the treatment groups (Fig. 2.5C). In addition, the treatment with RU486
alone did not affect the relative amounts of αENaC, βENaC, or γENaC subunit mRNAs (Fig.
2.5D). Taken together, these results indicate that GR antagonism was able to attenuate the effect
of corticosterone on γENaC expression. These results suggest an independent pathway involving
the GR-corticosterone complex and regulating ENaC expression in VP neurons in the
hypothalamus.
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Fig. 2.5. The effect of corticosterone on ENaC subunit expression in hypothalamic slices. A. No
significant differences in the relative amounts of αENaC and βENaC subunit mRNAs occurred
between the respective sides of the hypothalamic slices that were incubated with and without
corticosterone, respectively; however, the sides that were incubated with corticosterone had a
significantly higher γENaC subunit expression compared to those sides incubated with vehicle
only (*p<0.007). B. No significant differences in αENaC, βENaC, or γENaC subunit expression
occurred between the sides of the hypothalamic slices that were pre-incubated with and without
MR antagonist, RU-28318, respectively. C. No differences in αENaC and βENaC subunit
expression occurred between the hypothalamic slices that were pre-incubated with and without
GR antagonist, RU486, respectively; however, the hypothalamic slices that were not preincubated with RU486 had a significantly higher γENaC subunit expression compared to those
pre-incubated with RU486 (**p<0.037). D. No significant differences in αENaC, βENaC, or
γENaC subunit expression observed between the sides of the hypothalamic slices that were
incubated with and without RU486.
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Subcellular distribution of ENaC subunit immunoreactivity
In the region of the hypothalamus used for semi-quantification of the ENaC subunit
mRNAs and proteins in the present study, immunoreactivity of the ENaC subunits was
exclusively found in magnocellular neurons in the SON and PVN (Fig. 2.6 A&B). No
immunoreactivity of ENaC subunits was observed in the ependymal cell layers or in the
endothelium of blood vessels. Because our recent study showed αENaC labeling was
distinctively concentrated near the plasma membrane in neurons from animals that were fed a
high salt diet (Sharma et al., 2017), the effect of aldosterone on the subcellular distribution of
ENaC subunits immunoreactivity was also examined. Intense αENaC immunoreactivity that was
moderately concentrated towards the plasma membrane was observed in most of the
magnocellular neurons; however, no noticeable differences in subcellular distribution of ENaC
immunoreactivity occurred between control and aldosterone treated hypothalamic slices from six
different animals (Fig. 2.6C). Weak immunoreactivity of βENaC was observed in the cytoplasm
of magnocellular neurons (Fig. 2.6C). In contrast to βENaC immunoreactivity, γENaC
immunoreactivity was intense and fully filled the cytoplasm of magnocellular neurons (Fig.
2.6C).
Effect of corticosteroids on vasopressin expression
In the kidney, VP promotes Na+ reabsorption by inducing the expression of β- and γENaC subunits (Djelidi et al., 1997; Ecelbarger et al., 2000; Nicco et al., 2001; Sauter et al.,
2006) and the translocation of intracellular pools of pre-existing ENaC subunits to the apical
membrane of the principal cells in the collecting duct (Schafer & Hawk, 1992). The effect of
aldosterone and corticosterone on the expression of VP was assessed to evaluate possible effect
of corticosteroid-induced VP on ENaC activity. Semiquantitative PCR found that neither
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incubation with aldosterone nor corticosterone produced changes in expression of VP in the
hypothalamic slices (Fig. 2.7).

A

B
PVN
SON
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βENaC

γENaC

CTRL

Aldo

Fig. 2.6. Immunocytochemical localization of γENaC in the hypothalamic slices. A.
Immunoreactivity to γENaC was exclusively found in the magnocellular neurons in both the
SON and SON. Although a limited number of neurons located in the area between the SON and
PVN were also immunoreactive to γENaC; no other prominent immunoreactivity was found in
the hypothalamic slices. B. In the SON, immunoreactivity to γENaC was exclusively found in
the magnocellular neurons. C. Confocal microscopy of αENaC, βENaC, and γENaC
immunoreactivities in magnocellular neurons in the SON from hypothalamic slices that were
treated with aldosterone and vehicle only. The αENaC immunolabeling within neurons was
moderately concentrated towards the plasma membrane; no noticeable differences in subcellular
distribution of αENaC immunoreactivity occurred between control and aldosterone treated
hypothalamic slices. Intense γENaC immunoreactivity fully filled the cytoplasm. No noticeable
differences in subcellular distribution of βENaC or γENaC immunoreactivity occurred between
control and aldosterone treated hypothalamic slices. 1 µm optical section. Scale bars: 500 µm in
A; 100 µm in B; and 50 µm in C.
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Fig. 2.7. The effect of corticosteroids on VP expression in hypothalamic slices. A. No significant
differences occurred in the relative amounts of VP mRNA identified between the aldosterone
and vehicle only incubated sides of the hypothalamic slices. B. No significant differences
occurred in the relative amounts of VP mRNA identified between the sides of hypothalamic
slices that were incubated with and without corticosterone.
Effect of aldosterone on the benzamil-sensitive current
Of forty-five recorded VP neurons from 21 rats, 25 neurons were from the aldosteronetreated side, and 20 neurons were from the control side. From these recorded VP neurons, 12
(48%) recorded neurons from the aldosterone-treated sides and 6 (30%) recorded neurons in the
control sides showed a decrease (> 2.5 pA) in the steady state inward current held at -80 mV in
response to the application of benzamil (Fig. 2.4.8A). The benzamil-sensitive current was
obtained from the difference in the steady state currents before and after the application of
benzamil. The mean benzamil-sensitive current was similar in VP neurons from both the
aldosterone-treated (13.1 ± 3.8 nA) and control (11.7 ± 5.4 nA: Fig. 2.4.8B) sides. The effect of
aldosterone on cell size was assessed by measuring the membrane capacitance of the recorded
neurons.

56

A
a

b

-60
-80
-100

pA

no Benzamil

-120

10 pA
1s

-140
2 μM Benzamil

-160
0

50

100

150

200

Benzamil

250

S

B

C
Benzamil sensitive
current (pA)

membrane capacitance
(pF)
50

50

40

40

30

30

20

Benzamil sensitive
current density (pA/pF)
1.5

1.0

20

n=n

0.5

10

10
0

D

0
Aldo

CTRL

Aldo

0
CTRL

Aldo

CTRL

Fig. 2.8. The effect of aldosterone on benzamil-sensitive current. Aa. An example of the effect
of benzamil on the steady state current in a VP neuron. The steady state current was measured in
voltage clamp while the cell was held at -80 mV. Ab. Brief hyperpolarizing pulses (15 mV, 200
ms) were injected every 5 s to monitor the input resistance of the cell. Bath application of
benzamil (2 µM) reduced the resting inward current and decreased conductance by
approximately 1.5-fold. A benzamil sensitive current was obtained by changes in the steady state
current in response to its application. B. The mean benzamil-sensitive current did not differ in
VP neurons from the aldosterone-treated and control sides. C. The mean whole cell membrane
capacitance of VP neurons did not differ between the aldosterone-treated side and that from the
control sides. D. There was no difference in the mean benzamil sensitive current density in VP
neurons between the aldosterone-treated side and control sides. Experiments performed by: K.
Sharma
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The mean whole cell membrane capacitance did not differ between the aldosteronetreated (27.79 ± 2.55 pF) and control (23.02 ± 2.41 pF) sides, indicating that a hypertrophy of VP
neurons did not occur in response to the aldosterone exposure (P=0.252; Fig. 2.4.8B).
Subsequently, the benzamil-sensitive current was normalized by the whole-cell capacitance, and
the current density (pA/pF) was obtained. The mean current density (0.47 ± 0.16 nA/pF) of VP
neurons from the aldosterone treated hypothalamic slices did not differ from that (0.57 ± 0.18
nA/pF: Fig. 2.4.8C) in VP neurons from the control hypothalamic slices.
Discussion
Aldosterone directly induced the expression of γENaC via MR in VP neurons
The present study demonstrated that incubation of hypothalamic slices with aldosterone
resulted in induction of γENaC subunit expression, whereas αENaC and βENaC subunit
expression remained at basal levels. Antagonism of the MR attenuated the effect of aldosterone
on γENaC expression, indicating that aldosterone induced γENaC genomic change via the MR in
the hypothalamic slices. Moreover, the result from our ChIP experiment indicated that the
aldosterone-MR complex directly interacts with the hormone-responding element on the γENaC
gene. The structures that express ENaC were found only in magnocellular neurons in the PVN
and SON in the hypothalamic slices used in this study. γENaC immunoreactivity was identified
prominently in the VP neurons in the SON and PVN in our previous study (Teruyama et al.,
2012a), suggesting the aldosterone-MR mediated regulation of γENaC expression most likely
occurred specifically in VP neurons.
Corticosterone induces the expression of γENaC via GR in VP neurons
Another major finding of the present study is that corticosterone incubation resulted in a
significant increase in γENaC expression, similar to the expressional changes observed

58

subsequent to aldosterone incubation. Because corticosterone binds to both the GR and MR with
similar affinity (Beaumont & Fanestil, 1983; Krozowski & Funder, 1983; Reul & de Kloet,
1985; Sheppard & Funder, 1987a; Sheppard & Funder, 1987b; Funder, 1995), antagonists for
MR and GR were used to elucidate which receptor was activated to induce the γENaC
expression. Antagonism of the MR was unable to prevent this effect of corticosterone on γENaC
expression; however, an antagonist of the GR did attenuate induction of γENaC expression in the
presence of corticosterone. These results indicate that corticosterone preferentially binds to the
GR rather than to the MR in VP neurons to induce γENaC expression.
Although plasma concentrations of glucocorticoids are substantially higher than those of
aldosterone (Holbrook et al., 1980), aldosterone is known to preferentially bind to the MR in
aldosterone sensitive-epithelia (Odermatt et al., 2001). Aldosterone selectivity of the MR in the
epithelia is achieved by inactivating intracellular glucocorticoids through the glucocorticoidinactivating enzyme, 11β–hydroxysteriod dehydrogenase type 2 (11β-HSD2) (Gomez-Sanchez et
al., 2005b), which converts corticosterone into inactive metabolites (Funder, 1995; Naray-FejesToth et al., 1998). Thus, our present observation may be explained by our previous finding that
11β-HSD2 is expressed in the MR-expressing neurons in the SON and PVN (Haque et al.,
2015).
Regulation of γENaC in VP neurons by aldosterone and corticosterone
Both the MR and GR belong to the nuclear receptor super family that act as transcription
factors regulating gene expression (Vallon et al., 2005; Ronzaud et al., 2007; Ackermann et al.,
2010). Upon hormone binding in the cytosol, the MR forms homodimers and heterodimers with
the GR and is translocated into the nucleus where it binds to the hormone-responsive element of
the target gene (Ou et al., 2001; Gekle et al., 2014). Since the DNA binding domains of the MR
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and GR share approximately 94% amino acid homology (Viengchareun et al., 2007), both the
MR and GR are thought to bind the common hormone-responsive elements in a sequencespecific manner to regulate some of the same genes (Evans & Arriza, 1989). The present finding
that corticosterone-GR induced γENaC expression in a manner similar to that of aldosterone-MR
in the hypothalamus may be due to the activation of common hormone-responsive elements on

γENaC by the GR and MR.
Aldosterone alone does not cause increase in ENaC activity in VP neurons
Our recent study showed that the enhanced ENaC activity in response to high dietary salt
intake was associated with an increase in the expression of both βENaC and γENaC subunits in
the SON, as well as translocation of ENaC towards the plasma membrane (Sharma et al., 2017).
These changes in the expression of the βENaC or the subcellular translocation of ENaC were not
observed in the hypothalamic slices exposed to aldosterone in vitro. Therefore, other factors
involving in induction of βENaC and translocation of ENaC to fully activate ENaC in VP
neurons were not activated in the hypothalamic slices in media with aldosterone.
VP is known to induce the expression of βENaC subunits in the kidney (Djelidi et al.,
1997; Ecelbarger et al., 2000; Nicco et al., 2001; Sauter et al., 2006). Of the three characterized
VP receptor subtypes (V1a, V1b, and V2), VP appears to act through the V2 VP receptor to
induce gene expression of βENaC (Nicco et al., 2001) in the kidney. VP also stimulates the
translocation of intracellular pools of pre-existing ENaC subunits to the apical membrane of the
principal cells in the collecting duct promoting Na+ reabsorption in the kidney (Schafer & Hawk,
1992). VP neurons not only secrete VP at nerve terminals in the neurohypophysis, but also
release VP from their soma and dendrites in the extracellular space of the SON and PVN
(Landgraf & Ludwig, 1991; Neumann et al., 1993; Ludwig, 1998). The V2 receptor was shown
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to mediate the ability of the somato-dendritically released VP to facilitate cell volume regulation
in VP neurons (Sato et al., 2011). The presence of V2 receptors on VP neurons suggests the
possibility that βENaC in VP neurons could be regulated by the somato-dendritic release of VP
by mechanisms similar to their regulation in the nephron. Unlike high dietary salt intake,
aldosterone did not cause an increase in VP expression in this study. Thus, the lack of
enhancement in VP expression in response to aldosterone treatment may be the reason for the
lack of a change in βENaC expression and translocation of ENaC in VP neurons.
Effect of aldosterone on ENaC in the brain in vivo
Our recent study (Sharma et al., 2017) found that a NaCl deficient diet, which is known
to cause an increase in aldosterone in the general circulation (Frindt et al., 1990; Pacha et al.,
1993; Asher et al., 1996), did not cause a change in ENaC expression in the SON. However, the
NaCl deficient diet did cause an increase in αENaC mRNA in the kidney known to occur in
response to elevated aldosterone caused by such a diet (Renard et al., 1995; Asher et al., 1996;
Escoubet et al., 1997; Stokes & Sigmund, 1998b; Masilamani et al., 1999; MacDonald et al.,
2000). Instead, a high NaCl diet, which is known to decrease circulating aldosterone, caused an
increase in βENaC and γENaC mRNAs in the SON (Sharma et al., 2017). This finding implies
that plasma aldosterone has no effect on ENaC expression in VP neurons. Despite the
lipophilicity of steroids, aldosterone is known to have a surprisingly poor penetration of the
blood-brain barrier (BBB) (Pardridge & Mietus, 1979; Funder & Myles, 1996; Parker et al.,
2006). This also agrees with the finding in rats that subcutaneous infusion of aldosterone
increased plasma aldosterone level without significant changes in hypothalamic aldosterone
content (Huang et al., 2010). Therefore, the induction of γENaC expression in VP neurons by
plasma aldosterone in vivo is somewhat questionable.
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One possible explanation for this is that aldosterone-MR-ENaC pathway in the brain is
regulated independently of the peripheral/renal pathway. A growing body of evidence now
suggests that aldosterone is synthesized in the CNS. The ability of brain tissue to synthesize
aldosterone was demonstrated in vitro (Gomez-Sanchez et al., 2005a). Transcripts of aldosterone
synthase (CYP11B2) were detected in various brain regions including the hypothalamus
(MacKenzie et al., 2000). The presence of aldosterone synthase was detected by in situ
hybridization in magnocellular neurons in the SON (Wang et al., 2016). Furthermore, ICV
infusion of Na+-rich ACSF caused in rats an increase in hypothalamic aldosterone concentration
and blood pressure, and both were prevented by ICV infusion of an aldosterone synthase
inhibitor (Huang et al., 2008). Thus, aldosterone synthesis in the hypothalamus may be
stimulated by a high concentration of Na+ in the CSF. Together with the present finding that
γENaC in the hypothalamus is induced by aldosterone, the high-salt diet induced expression of
γENaC in the SON found in our previous study was mediated by aldosterone that was
synthesized locally.
Another possible explanation is that high dietary salt intake affects gene expression of
γENaC via the glucocorticoid-GR pathway, instead of or in addition to the locally synthesized
aldosterone-MR pathway. The present study showed corticosterone induced γENaC expression
via GR in the hypothalamus. Thus, it is possible that the stress induced by high dietary salt intake
increased the circulating level of corticosterone that crossed the BBB and affected γENaC
expression via the GR.
Limitations of this study
The physiological plasma concentration of aldosterone (<0.1 µM) did not induce gene
expression of ENaC subunits in in vitro hypothalamic slices. The concentration of aldosterone
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used in this study was supra-physiological. For humans, this aldosterone concentration in plasma
would be above the pathological range (Mattsson & Young, 2006). The supra-physiological dose
was probably required for aldosterone to penetrate the relatively thick 250 µm hypothalamic
slices without a functional vascular system. One of the concerns for using a supra-physiological
concentration of corticosteroids is that these steroids may bind to other steroid receptors at that
concentration. However, the effects of aldosterone and corticosterone on γENaC expression was
attenuated by both MR and GR antagonists, respectively. In addition, the effect of corticosterone
on γENaC expression was not attenuated by a MR antagonist, suggesting that the high
concentration of the MR antagonist did not affect off-target receptors. Considering the presence
of MRs in VP neurons (Teruyama et al., 2012a; Haque et al., 2015) and the direct interaction of
MR with the hormone responding element on the γENaC gene in the SON demonstrated by the
present ChIP experiment, it is reasonable to interpret that aldosterone induces the expression of
γENaC in VP neurons.
Physiological relevance and Conclusion
Several in vivo studies suggest that ENaC in the brain are activated by aldosterone. In
normotensive rats, ICV infusion of aldosterone increases blood pressure (Wang & Leenen, 2002,
2003). In salt-sensitive Dahl rats, high-salt diet or ICV infusion of aldosterone causes
hypertension, but ICV infusion of a MR antagonist prevents the development of hypertension
(Gomez-Sanchez et al., 1992). Intriguingly, ICV infusion of amiloride or benzamil prevents saltinduced hypertension in salt-sensitive Dahl rats (Gomez-Sanchez & Gomez-Sanchez, 1994;
Wang & Leenen, 2002), as well as the hypertension induced by ICV infusion of aldosterone in
normal rats (Gomez-Sanchez & Gomez-Sanchez, 1995). These findings suggest that aldosteronemediated ENaC activation in the brain is involved in the regulation of blood pressure.
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ENaC subunits and MR in the brain are colocalized only in limited regions, namely the
SON, PVN, subfornical organ, choroid plexus, and ependyma of the anterovental third ventricle
(Amin et al., 2005; Teruyama et al., 2012a; Haque et al., 2015). In these brain structures, VP
neurons in the PVN and SON are the only structures that directly stimulate both endocrine and
autonomic responses to maintain cardiovascular homeostasis. In addition to the wellcharacterized endocrine role of VP on antidiuretic and pressor effects, the somato-dendritic
release of VP stimulates the activity of parvocellular neurons that project to the rostral
ventrolateral medulla (Son & Stern, 2011), thereby leading to increase in both sympathetic
outflow and blood pressure (Dampney, 1994).
ENaC in VP neurons mediate a steady state Na+ leak current that regulates the basal
membrane potential (Teruyama et al., 2012a; Sharma et al., 2017). More depolarized basal
membrane potential observed in VP neurons in response to high dietary salt intake was caused
by increased ENaC expression and activity (Sharma et al., 2017). Therefore, activation of ENaC
raises the basal membrane potential closer to the action potential threshold and consequently
augments synaptic drive. Because the release of VP is regulated largely by the frequency and
pattern of action potential firing in their synthesizing neurons (Poulain & Wakerley, 1982;
Cazalis et al., 1985), ENaC activity in VP neurons could directly influence the release of VP and
autonomic responses. Thus, the physiological conditions that require VP, such as an excess
dietary salt intake, may promote release of VP through ENaC activation.
The present study identified a direct involvement of aldosterone and corticosterone on
γENaC expression in VP neurons via the MR and GR, respectively. Thus, aldosterone and
corticosterone are likely involved in activation of ENaC in VP neurons in response to the
physiological demand for VP. However, aldosterone itself is not sufficient to induce activation of
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ENaC in VP neurons, as neither induction of βENaC subunits nor translocation of ENaC to the
plasma membrane were observed after incubation with aldosterone. Therefore, the mechanism
underlying the regulation of ENaC activity in VP neurons remains largely unknown.
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CHAPTER 3
EFFECT OF DIETARY SALT ON EPITHELIAL NA+ CHANNELS (ENAC)
IN THE HYPOTHALAMUS OF DAHL SALT-SENSITIVE RATS
Introduction
In the paraventricular (PVN) and supraoptic nuclei (SON) of the hypothalamus,
magnocellular neurosecretory cells (MNCs) synthesize the neurohypophysial hormones,
vasopressin (VP) and oxytocin (OT). Synthesis and release of VP into the general circulation is
promoted by physiological demands to maintain body fluid homeostasis. During times of
hyperosmolarity (Brimble & Dyball, 1977), hypovolemia (Harris et al., 1975), and hypotension
(Khanna et al., 1994), VP release is enhanced to produce pressor and antidiuretic effects to
counter these physiological changes (Antunes-Rodrigues et al., 2004). Additionally, VP is
released from the soma and dendrites of VP neurons located in the PVN to enhance the activity
of the parvocellular neurons that project to the rostral ventrolateral medulla to cause an increase
in sympathetic outflow and blood pressure (Son et al., 2013). Given these systemic effects of
VP, it is clear that VP plays an essential role in coordinating neuroendocrine and autonomic
activities to maintain cardiovascular homeostasis.
The non-voltage dependent, amiloride-sensitive, epithelial Na+ channel (ENaC) is
expressed within the apical membrane of the epithelium involved in trans-epithelial Na+
transport (Canessa et al., 1994; Harris et al., 2008), such as the distal colon and renal collecting
duct in the kidney (Kellenberger & Schild, 2002). ENaC expression was also demonstrated in
various regions of the brain involved in cardiovascular control, such as the PVN, SON and
choroid plexus (Amin et al., 2005). Our previous study showed that all ENaC subunits (α, β, and
γ) are expressed specifically in VP MNCs, and functional ENaC channels modulate the
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membrane potential of VP neurons by mediating a Na+ leak current (Teruyama et al., 2012).
Additionally, we demonstrated the mineralocorticoid receptor (MR), a known ENaC regulator, is
present in VP neurons (Teruyama et al., 2012; Haque et al., 2015).
It is well-known that dietary salt regulates ENaC expression in aldosterone-sensitive
epithelia (Garty & Palmer, 1997; Stokes & Sigmund, 1998), such as the renal collecting duct
(Masilamani et al., 1999). Interestingly, central administration of amiloride, an ENaC blocker,
and its analog, benzamil, attenuates hypertension in several animal models of hypertension
(Gomez-Sanchez & Gomez-Sanchez, 1994, 1995; Nishimura et al., 1998; Keep et al., 1999).
Additionally, we recently demonstrated that ENaC activity in VP neurons is affected by
increased dietary salt intake in normotensive rats (Sharma et al., 2017). These findings suggest
that central ENaC expression and activity are involved in hypertension development. The effect
of dietary salt on ENaC expression within VP neurons during salt-sensitive hypertension remains
unknown. The present study was conducted to examine ENaC expression during high dietary salt
intake in salt-sensitive states utilizing Dahl salt sensitive (Dahl-SS) rats, an established animal
model for salt-sensitive hypertension (Rapp, 1982). Findings from this study indicate that ENaC
expression within VP neurons is altered in Dahl-SS rats during high dietary salt intake, which
may provide some insight into the etiology of salt-sensitive hypertension.
Methods
Animals
Male Sprague Dawley (SD) and Dahl-SS rats (ENVIGO, Indianapolis, IN) weighing
between 260-300g were used for this study. Rats were housed on a 12:12 hr light-dark cycle. All
protocols were approved by the Institutional Animal Care and Use Committees of Louisiana
State University.
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Tissue Sample for Real-time RT-PCR and Semiquatitative immunoblotting
Rats were fed standard chow (0.4% NaCl) or high salt (8% NaCl) (Teklad diet
Indianapolis, IN) for 21 days and water ad libitum. On the 21st day, animals were sacrificed and
tissue was collected for real-time RT-PCR or semiquatitative immunoblotting. Rats were deeply
anaesthetized using Ketamine-Xylazine (9:1, 100 mg/kg i.p.) and approximately 1 ml of blood
was collected from each anesthetized animal by a 21-gauge needle inserted into the left ventricle
directly before cardiac perfusion. Animals were then perfused through the heart with cold
artificial cerebral spinal fluid (aCSF), in which NaCl was replaced by equiosmolar amount of
sucrose containing (in mM): 210 Sucrose, 3 KCl, 2.0 CaCl2, 1.3 MgCl2, 1.24 NaH2PO4,
25 NaHCO3, 0.2 ascorbic acid, and 10 D-glucose (pH 7.4). Brains were removed and three
coronal slices (500 µm) containing the SON and PVN were collected using a vibrating
microtome (Leica VT1200; Leica, Mannheim, Germany). Slices were trimmed along the dorsal
and lateral edges to exclude tissue that did not contain the PVN and SON and then stored in
RNAlater (Qiagen, Valencia, CA) at -20 °C for real-time RT-PCR or RIPA Buffer (SigmaAldrich, St Louis, MO) and processed for semiquatitative immunoblotting. Additionally, during
tissue collection for real-time RT-PCR, one of the kidneys from each animal was also removed,
minced, and saved in RNAlater for processing.
Real-time RT-PCR
Total RNA was isolated using TriReagent (Sigma-Aldrich, St Louis, MO) according to
the manufacture’s instructions and tissue was homogenized using a tissue lyser (Qiagen, CA).
Lysate was then treated with chloroform (Thermo-Fisher Scientific) and centrifuged at 12,000
rpm for 15 min. Total RNA was precipitated from the aqueous phase using isopropyl alcohol and
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washed with ethanol. The precipitate was suspended in 20 µl RNAase-free water (Qiagen, CA).
Concentration and quality of isolated RNA was assessed using a spectrophotometer (NanoDrop
1000, ThermoFisher Scientific, Waltham, MA). Isolated mRNA was reverse transcribed to
cDNA using oligo dT and M-MLV reverse transcriptase (Sigma-Aldrich, St. Luis, MO) and used
in real-time RT-PCR analysis. ABI ViiA-7 sequence detection system (ABI Applied Biosystem,
Grand Island, NY) was used in conjunction with SYBR Select Master Mix (ABI Applied
Biosystem, Grand Island, NY). All samples were measured with three replicates and the two
closest cycle threshold (Ct) values were averaged for each sample. Quantitative PCR primers
were designed using Primer 3 software (Whitehead Institute for Biomedical Research) and
purchased from Sigma-Aldrich (St. Louis, MO). All primer sequences were specifically designed
to amplify the cDNA of interest (Table 1) and have been used successfully (Amin et al., 2005;
Teruyama et al., 2012). The effect of the treatments was examined through the relative change of
the specific target genes, which were calculated through the comparative cycle threshold method.
For each sample, the average cycle threshold (Ct) value of the target gene was subtracted by the
housekeeping (Cyclophilin B) Ct value to obtain the ΔCt value. The ΔCt values of the designated
control group were averaged and subtracted from each sample to generate the ΔΔCt value. The
relative change was calculated for each sample by using the formula 2 - ΔΔCt. All results are
shown as relative change in comparison to the control. The Student’s t test was used for
comparison between treatment groups. Differences were considered to be statistically significant
at p< 0.05.
Plasma osmolality
Collected blood samples were centrifuged at 12,000 rpm for 20 min at 4 °C and the
supernatant was collected and placed in a chilled 1.5 ml centrifuge tube. The collected
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supernatant was centrifuged for 5 min at 12,000 rpm at 4 °C, and the resulting supernatant was
collected and stored at -20° C for later processing. Osmolality of the blood samples was
measured using an osmometer (5004 Micro-osmette, Precision System Inc., Natick, MA). The
Student’s t-test was used for comparison between treatment groups. Differences were considered
to be statistically significant at p< 0.05.
Semiquatitative immunoblotting
Total protein lysate samples were collected from the hypothalamic slices. Tissue samples
were rinsed with cold phosphate buffer solution and placed in microcentrifuge tubes containing
250 µl of chilled complete lysis buffer that was made fresh before each experiment. Complete
buffer contained: RIPA buffer (50 mM NaCl, 1.0% IGEPAL® CA-630, 0.5% sodium
deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0; Sigma-Aldrich), protease inhibitors
(ProteoGuardTM EDTA-free protease inhibitor cocktail; Takara Clontech), 1 mM EGTA, 1 mM
EDTA, and 1mM DTT (Sigma-Aldrich, St. Louis, MO). Samples were briefly homogenized with
an electric tissue lyser (Qiagen, Valencia, CA) and allowed to stand on ice for 10 min. Lysed
samples were centrifuged for 20 min at 12,000 rpm at 4°C. The pellet was discarded and the
supernatant (total lysate) was transferred to a clean tube to be stored at -20°C for later
processing.
The protein concentration was determined (BCA kit; Pierce Chemical Co., Rockford,
Illinois, USA); samples (15-20 µg of protein) were denatured by heating in 1x Laemmli buffer
(Bio-Rad, Hercules, CA) for 5 min at 95 °C. Samples were resolved in a 4-15% SDS-PAGE
(Mini PROTEAN Precast Gels, Bio-Rad, Hercules, CA) gradient gel in Tris-glycine buffer (25
mM, 192 mM glycine, 0.1% SDS, pH 8.3; Bio-Rad) and transferred to a PVDF membrane (BioRad, Hercules, CA) under wet conditions (50V for 2 hr at 4°C). To determine a successful
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transfer, the membrane was stained with Ponceau S solution (Sigma-Aldrich, St. Louis, MO) for
approximately 1 min. The membrane was destained with 0.1 M NaOH for 30 sec followed by a 1
min TBST (Tris-GlycineTween; 50 mM Tris base, 200 mM NaCl, 0.05% Tween 20) wash. The
membrane was treated with 5% non-fat milk buffer (NFM; Bio-Rad) for 1 hr at room temp. The
membrane was incubated overnight at 4 °C with the selected primary antibody dissolved in 5%
NFM buffer. A final concentration for all primary antibodies was 1 µg/ml. The membrane was
washed three times for 10 min each with TBST and incubated with goat-anti-rabbit horseradish
conjugated secondary antibody (1:10,000; Bio-Rad) dissolved in 5% NFM buffer at room temp
for 2 hr followed by six TBST washes for 10 min each. Protein bands were detected through
chemiluminscence reagents (ClarityTM Western ECl Substrate Kit; Bio-Rad) and imaged using a
gel imaging system (ChemiDocTM XRS+; Bio-Rad). Densitometric analyses of the images were
performed using ImageJ (National Institutes of Health, Bethesda, MD). Measurements were
normalized by subtracting background values of the collected image. Densometric measurements
were analyzed as a comparison between rat strain and dietary treatment for individual animals
using a Student’s t-test and considered significantly different at p<0.05.
Immunocytochemistry
Rats fed high salt or control diet for 21 days were deeply anaesthetized using KetamineXylazine (9:1, 100 mg/kg i.p.) and transcardially perfused with 0.01 M sodium phosphate
buffered saline (PBS, pH 7.2) followed by 4% paraformaldehyde in 0.1 M PBS (pH 7.2).
Animals were decapitated and the heads were postfixed in the same fixative for 1-3 days. Brains
were removed and placed in 20% sucrose in 0.1 M PBS overnight for cryoprotection. Coronal
sections at 40 µm were collected by a sliding microtome (SM2010R; Leica, Mannheim,
Germany). Slices were incubated with the primary antibody against γENaC at a dilution of
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1:4,000 in PBS containing 0.5% Triton X-100 (PBST) at 4 °C with continuous, gentle agitation
overnight. The antibodies used for the ENaC subunits were a generous gift from Dr. Mark A.
Knepper (National Institutes of Health, Bethesda, MD) and were previously described in great
detail (Masilamani et al., 1999). Slices were incubated with biotinylated goat-anti-rabbit IgG
(1:500 in PBST; Vector, Burlingame, CA) for 2 hr followed by incubation with the ABC
complex (1:500 in PBST, Vector, Burlingame, CA) for 1 hr at room temperature. Finally, slices
were incubated with diaminobenzidine (DAB; Vector, Burlingame, CA) for 6 min to visualize
immunoreactivity. The brains were mounted on gelatin-coated slides, dehydrated, cleared, and
cover slipped with Permount (Thermo Fisher Scientific, Waltham, MA). Images were acquired
digitally (Eclipse 80i equipped with a digital camera, DS-QiMc, Nikon, Tokyo, Japan). Digital
images of both sides of the SON were acquired from each animal and analyzed using ImageJ
(National Institutes of Health, Bethesda, MD). The total number of immunoreactive cells was
obtained using the Cell Counter ImageJ plugin and densometric measurements of each cell were
assessed for each animal. Background measurements were collected for each section and cell
optical density measurements were subtracted to obtain normalized values. Normalized
measurements that had an optical density 75% higher than the background measurement was
classified as having dense immunocytochemistry staining. Measurements were analyzed using a
Student’s t test and considered significantly different at p<0.05.
Time course plasma osmolality collection
A separate set of male SD and Dahl-SS rats were used to measure the changes in plasma
osmolality over time in response to dietary salt. Blood samples (0.1ml) were collected every
morning, alternating between left and right tail veins. Samples were stored in 4 °C for 30 min to
let the blood clot and centrifuged at 10,000 rpm for 8 min at 4 °C. The supernatant was collected
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to check the osmolality as described above. After the initial seven days of sampling on control
diet to measure the baseline plasma osmolality of each animal, all rats were fed high salt (8%
NaCl) diet ad libitum for 22 days with free access to drinking water.
Results
Dietary salt increases hypothalamic γENaC, OT, and VP expression in Dahl-SS rats
The effect of dietary salt on the expression of ENaC subunits, VP, OT, and MR in the
hypothalamus of Dahl-SS rats was assessed by the relative difference in amount of mRNA
between groups for each of the genes (See Fig. 3.1). Significantly higher γENaC subunit
expression was observed in Dahl-SS rats fed a high salt diet compared to those fed the control
diet (p=0.025). In contrast, there was no difference in the α- and βENaC subunit expressions
between dietary treatments. Expression of VP and OT was also significantly increased in
response to high dietary salt compared to that of the control diet (p=0.007 and p=0.011,
respectively). Additionally, ENaC expression in the kidney was examined in Dahl-SS rats fed
control or high salt diet. In contrast to hypothalamic ENaC expression, no difference was
observed in kidney ENaC subunit expression between treatment groups (Fig. 3.1B).
SD rats fed high dietary salt have decreased αENaC in the kidney and MR
expression in the hypothalamus
The effect of dietary salt was also assessed on the hypothalamic expression of ENaC
subunits, VP, OT, and MR in SD rats (See Fig. 3.2). No difference was observed in the
hypothalamic ENaC subunit expression between dietary treatments. Hypothalamic MR
expression, however, was significantly lower in SD rats fed a high salt diet compared to those
fed the control diet (p=0.048). Expression of VP and OT was significantly higher in SD rats fed
high salt diet (p=0.047 and p=0.024, respectively). Additionally, ENaC expression in the kidney
was examined (Fig. 3.2B), and SD rats fed a high salt diet had significantly lower αENaC
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expression compared to those fed the control diet (p=0.005). There was no detectable difference
in the kidney β- and γENaC expressions between dietary treatments.
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Fig. 3.1. Dietary salt intake increases hypothalamic γENaC, VP, and OT expression in Dahl-SS.
A. Dahl-SS rats fed high salt diet for 21 days had significantly higher γENaC, VP, and OT
mRNA expression in the hypothalamus compared to animals fed control diet, whereas MR, αand βENaC hypothalamic mRNA expression was not affected by dietary treatment. B. No
significant difference was detected in ENaC mRNA expression in the kidney between animals
fed high salt diet or control.
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Fig. 3.2. SD rats fed high dietary salt had decreased MR in the hypothalamus and αENaC
expressions in the kidney. A. No significant difference was detected in hypothalamic ENaC
subunit expression between treatment groups; however, SD rats fed high salt diet had
significantly lower MR mRNA expression and significantly higher VP and OT mRNA
expression compared to animals fed control diet. B. Expression of αENaC mRNA in the kidney
was significantly lower in animals fed high salt diet compared to those fed control diet; however,
no difference was detected in the β- and γENaC expressions between diet treatments.
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Dahl-SS rats have increased hypothalamic γENaC abundance and proteolytic
cleavage
Proteins were extracted from the hypothalamus of SD and Dahl-SS rats fed control or
high salt diet for 21 days. The effect of dietary salt intake on the ENaC subunits abundance was
assessed by semi-quantitative immunoblotting (Fig. 3.3). From the protein extract, a distinct
band was detected at the predicted molecular weight of 87 kDa and 85 kDa by the αENaC and
γENaC antibodies, respectively (Fig. 3.3A). A smaller, second band with a molecular weight of
70 kDa was detected by the γENaC antibody in Dahl-SS rats fed the high salt diet. There was no
band detected by the βENaC antibody in the protein extract from the hypothalamus. Normalized
optical density (OD) measurements were compared between strains and showed that Dahl-SS
rats that were fed the control diet had a significantly higher abundance of the γENaC subunit
(113.7± 6.8 OD) compared to SD rats fed the control (91.79± 3 OD; p=0.017) or high salt
(86.66± 8.24 OD; p=0.007) diets. There was no difference in αENaC abundance between strains
or diet (Fig. 3.3B).
Dahl-SS rats fed high salt diet have significantly higher plasma osmolality
In addition to tissue collection, plasma samples were collected from rats fed a high salt or
a control diet for 21 days (Fig. 3.4). Dahl-SS rats fed the high salt diet exhibited a significantly
higher plasma osmolality compared to those fed the control diet (p<0.001). SD rats showed no
difference between dietary treatments. There was no difference detected in the plasma osmolality
of Dahl and SD rats fed control diet. Further experiments were conducted to determine if there
was a strain specific effect over time that could offer further explanation for discrepancies with
our previous study using SD rats fed high salt diet for 7-10 days and demonstrated changes in
hypothalamic ENaC expression.
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Fig. 3.3. Dahl- SS rats have increased γENaC abundance and dietary salt intake promotes
proteolytic cleavage of γENaC. A. Immunoblots showing the abundance and molecular weights
of ENaC subunits in SD and Dahl-SS rats fed high salt or control diet for 21 days. For each blot,
each lane is representative of an individual animal and loaded with protein extract from the
hypothalamus. Antibodies detected a single band for αENaC and γENaC at approximately 87
kDa and 85 kDa, respectively, in SD rats fed control or high salt diet and Dahl-SS rats fed
control diet. Dahl-SS rats fed high salt diet displayed a second, smaller band for γENaC at
approximately 70 kDa. No band was detected for βENaC for the extract regardless of strain or
diet treatment. B. Densometric measurements for each band of the αENaC immunoblot detected
no difference between strains or dietary treatments; however, densometric measurements for
each band of the γENaC immunoblot demonstrated significantly higher abundance in Dahl-SS
rats fed control diet compared to SD rats fed control diet (*p=0.017) and Dahl-SS rats fed high
salt diet compared to SD rats fed high salt diet (**p=0.007).
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Fig.3.4. Dahl-SS rats fed high salt diet for 21 days had increased plasma osmolality. SD rats fed
high salt diet for 21 days had no significant difference in plasma osmolality compared to animals
fed control diet, whereas Dahl-SS fed high salt diet had significantly higher plasma osmolality
compared to those fed control diet.
Dahl-SS rats fed high salt diet have a prolonged increase in plasma osmolality
To further examine the plasma osmolality difference observed, a time course collection
of plasma osmolality was completed in SD and Dahl-SS rats fed the high salt diet for 22 days
(Fig. 3.4.5). Plasma samples were collected for 7 days prior to starting the high salt diet to
establish a baseline osmolality for each group, which showed no difference between strains.
Within two days of starting the high salt diet, both strains had an increase in plasma osmolality.
SD rats had an increase in plasma osmolality until day 8 and then had a steady decrease to
baseline measurements by day 19. Dahl-SS rats had a prolonged increase in plasma osmolality
and plateaued at the peak after 15 days on the high salt diet. These results demonstrate a strain
difference effect that occurs over time and suggest SD rats exhibit a compensatory mechanism to
prevent hypertension development during chronic salt loading.
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Fig 3.5. Dahl-SS rats fed high salt diet had a prolonged increase in plasma osmolality. SD rats
that consumed high salt diet for 23 days had an initial increase in plasma osmolality that peaked
at day 8 and then gradually returned to baseline measurements by day 21. Dahl-SS rats had a
prolonged increase in plasma osmolality that peaked and plateaued at day 15. Experiments
performed by: K.Sharma
Dahl-SS rats have increased somato-dendritic γENaC immunoreactivity in the SON
Immunoreactivity of the γENaC subunit was examined in the SON of SD and Dahl-SS
fed a control or a high salt diet (Fig. 3.6). Localization of γENaC immunoreactivity among all
the animals examined was consistent and found exclusively in MNCs in the SON (Fig. 3.4.6A).
Dahl-SS rats fed the control diet had significantly more dense-immunoreactive cells in the SON
(46.67± 21.7) compared to SD rats (1±1) that were fed the control diet (p=0.019; Fig. 3.4.6B).
The total legnth of the immunoreactivy dendritic processes had a tendency to increase in length
in Dahl-SS rats fed high salt diet, but this was not found to be a significant difference due to the
low n- value used for this experiment.
84

A
SD
Control

SD
8% NaCl

Dahl-SS
Control

Dahl-SS
8% NaCl

B
105

# of γENaC dense
immunoreactive cells
*

85

*p=0.0193

65
45
15

Control 8% NaCl Control 8% NaCl
SD

Dahl-SS

Fig 3.6. Dahl-SS rats have increased somato-dendritic γENaC immunoreactivity in the SON A.
Photomicrographs shown are representative of an animal for each strain and diet treatment.
Immunoreactivity to γENaC was found exclusively in the MNCs of the SON in both SD and
Dahl-SS rats regardless of dietary treatments; however, Dahl-SS rats displayed dense cellular
immunoreactivity (arrows) as well as immunoreactive processes (arrowheads), which were not
observed in SD rats. B. The number of dense immunoreactive cells was significantly higher in
Dahl-SS rats compared to SD rats fed control diet; however, no difference was observed between
Dahl-SS rats fed control and high salt diet.
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Intra-strain analysis found no difference in the number of dense-immunoreactive cells between
dietary treatments. In addition to differences in immunoreactivity, Dahl-SS rats had γENaC
immunoreactive processes present (Fig. 3.6A). SD rats had no immunoreactive processes
detected in either dietary treatment. The total number of γENaC immunoreactive cells in the
SON was not affected by dietary treatment or strain type.
Discussion
The present study demonstrated that the expression and abundance of ENaC within the
hypothalamus is influenced by dietary salt in Dahl-SS rats. Specifically, Dahl-SS rats fed high
salt diet had increased γENaC expression in the hypothalamus, whereas the αENaC and βENaC
subunit expressions remained at basal levels. Regardless of diet treatment, Dahl-SS rats have
higher γENaC abundance in the hypothalamus compared to normotensive SD rats. In the
hypothalamic tissue examined, γENaC immunoreactivity was located prominently in the VP
MNCs of the SON and PVN (Teruyama et al., 2012), suggesting that changes in γENaC
expression in response to dietary salt intake occurred specifically in VP neurons.
It was previously shown in Dahl-SS rats that aldosterone is synthesized in the
hypothalamus (MacKenzie et al., 2000; Gomez-Sanchez & Gomez-Sanchez, 2003; GomezSanchez et al., 2005) and contributes to the development of salt-dependent hypertension in DahlSS rats (Huang et al., 2009; Gomez-Sanchez et al., 2010). Central aldosterone synthesis is higher
in Dahl-SS rats compared to SD rats and inhibition of aldosterone synthase attenuated the salt
induced hypertension in Dahl-SS (Gomez-Sanchez et al., 2010). Additionally, both aldosterone
synthase (Wang et al., 2016) and 11β–hydroxysteriod dehydrogenase type 2 (11β-HSD2), an
enzyme that promotes aldosterone binding to MR (Funder, 1995; Naray-Fejes-Toth et al., 1998),
are expressed in MNCs in the SON (Haque et al., 2015). This suggests the increased γENaC
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expression observed in Dahl-SS rats fed a high salt diet is a result of central aldosterone binding
to MR in VP neurons. In contrast, SD rats fed a high salt diet for 21 days resulted in a decreased
hypothalamic MR expression and no changes in hypothalamic ENaC expression. A previous
study demonstrated that inbred Dahl-salt resistant rats fed high salt diet had decreased
hypothalamic aldosterone levels independent from plasma aldosterone, suggesting an inhibitory
mechanism that decreased central aldosterone synthesis (Huang et al., 2009). These results
suggest that a high salt diet initiates a central pathway involving aldosterone-MR-ENaC in saltsensitive animals to increase VP neuronal activity and contribute to hypertension development.
Although full activity of ENaC requires all three subunits, changes in specific ENaC
subunit expression affects channel activity. Studies completed in cultured collecting duct cells
and human lung adenocarcinoma cells showed that selectively increasing γENaC expression by
an adenovirus system resulted in a three-fold increase in Na+ transport (Volk et al., 2005; Husted
et al., 2007) and a longer channel half-life (Volk et al., 2005). It was demonstrated in Xenopus
laevis oocytes that the γENaC subunit has specific domains that are important in increasing
channel surface expression and function (Konstas & Korbmacher, 2003). These findings, in
addition to our previous study examining the effects of dietary salt in SD rats (Sharma et al.,
2017), suggest that ENaC activity could be increased in VP neurons of Dahl-SS rats fed high salt
diet.
Additionally, our current study examined hypothalamic ENaC protein abundance in SD
and Dahl-SS rats. Regardless of diet treatment, Dahl-SS rats had a higher hypothalamic γENaC
abundance compared to SD rats. Dahl-SS rats fed a high salt diet resulted in a shift in the
molecular weight of the γENaC from 85 to 70 kDa. The proteolytic processing of ENaC is
important for the regulation of ENaC activity (Rossier, 2004; Kleyman et al., 2006). The
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proteolytic cleavage of the γENaC subunit releases an extracellular inhibitory domain (Passero et
al., 2010), which is necessary for full channel activation (Berman et al., 2015; Shobair et al.,
2016) and enhanced activity (Hughey et al., 2004). This shift in molecular weight was
documented in the kidney collecting tubule during salt deprivation to prevent sodium loss
(Masilamani et al., 1999). The proteolytic form of the γENaC subunit in the hypothalamus of the
Dahl-SS rats fed a high salt diet indicates enhanced ENaC activity in VP neurons in response to
physiological demands associated with increased dietary salt intake.
Plasma aldosterone is an important regulator of ENaC activity within epithelia, and
circulating levels are usually inversely correlated with dietary salt intake (Oki et al., 2012;
Funder, 2017). During the time of sodium restriction plasma aldosterone levels are elevated and
result in increased αENaC expression in the kidney distal tubule to prevent sodium waste (Asher
et al., 1996; Escoubet et al., 1997; Stokes & Sigmund, 1998; Masilamani et al., 1999; Sharma et
al., 2017). Conversely, during salt loading, plasma aldosterone levels decrease (Oki et al., 2012;
Funder, 2017). Our present study shows that SD rats fed a high salt diet have decreased kidney
αENaC expression compared to SD rats fed the control diet, which may be caused by low plasma
aldosterone levels to promote sodium excretion in the urine. In addition to the decreased
hypothalamic MR expression, decreased kidney αENaC during high salt diet intake may be part
of a compensatory mechanism to maintain sodium homeostasis and prevent development of saltinduced hypertension. This is further supported by the plasma osmolality measurements that
showed SD rats had an initial rise is plasma osmolality during high salt consumption, which
peaked on day 8 and then returned to levels comparable with baseline measurements.
Dendrites of MNCs contain peptide synthesis components to translate peptides that may
be needed locally in response to extracellular stimuli and increased neuronal activity, as well as

88

secretory components for vesicle exocytosis (Morris et al., 2000). Collected SON tissue from
Dahl-SS rats had dense γENaC immunoreactivity in cell bodies and dendrites. As demonstrated
in our previous study, dietary salt intake increased γENaC expression and associated enhanced
ENaC activity in VP neurons (Sharma et al., 2017). It is possible that the observed dendritic
γENaC immunoreactivity in Dahl-SS rats contributes to an enhanced VP neuronal activity,
which may be involved in the etiology of the development of salt-sensitive hypertension. Further
studies need to be conducted to determine if Dahl-SS rats have increased basal ENaC activity
compared to normotensive rats. Additionally, ENaC activity should be assessed in Dahl-SS rats
fed a high salt diet.
The findings from this study suggest that hypothalamic ENaC expression, specifically the
γENaC subunit, is involved in the etiology of salt-sensitive hypertension development in DahlSS rats. Given the role ENaC has in the resting membrane potential of VP neurons (Teruyama et
al., 2012; Sharma et al., 2017) and the enhanced ENaC activity in these neurons during high
dietary salt consumption (Sharma et al., 2017), it is possible that VP neurons exhibit enhanced
neuronal activity and subsequent hormone release that have large systemic effects.
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CHAPTER 4
CHARACTERIZATION OF THE 4B HYPOTHALAMIC CELL LINE AS A
POTENTIAL MODEL FOR EPITHELIAL SODIUM CHANNEL
REGULATION
Introduction
Epithelial sodium channel (ENaC) expression and function is regulated by a number of
hormones and signal transductions mechanisms that are dependent upon the tissue type, subunits
expressions, and secondary mediators present. Insulin has been demonstrated to stimulate Na+
reabsorption in different portions of the kidney, such as the distal collecting ducts (DeFronzo et
al., 1976; Feraille et al., 1995), thick ascending limbs (Veelken et al., 1988; Mandon et al., 1993;
Ito et al., 1997), and proximal tubule (Baum, 1987; Feraille et al., 1992; Feraille et al., 1994).
Insulin stimulates ENaC through secondary mediators (Mansley et al., 2016), which increase
channel open probability (Marunaka et al., 1992) and channel density at the cell membrane
(Blazer-Yost et al., 1998). Within the epithelia, ENaC expression is primarily regulated by the
main mineralocorticoid, aldosterone, binding to the mineralocorticoid receptor (MR) in a tissue
specific manner (Renard et al., 1995; Escoubet et al., 1997; Stokes & Sigmund, 1998;
Masilamani et al., 1999; MacDonald et al., 2000). Studies have also demonstrated that insulin
and aldosterone have synergistic anti-natriuretic effects (Miller & Bogdonoff, 1954; Fidelman &
Watlington, 1984; Johnson et al., 1986) through regulation of ENaC mediated Na+ transport
(Wang et al., 2001).
Given the limited expression of ENaC within the brain, such as the hypothalamus, (Amin
et al., 2005), detecting changes in expression and determining potential steps in a regulatory
pathway can be difficult. In order to further examine ENaC regulation in VP neurons, our lab
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obtained the immortalized 4B hypothalamic cell line from the lab of Dr. T. Cunningham (North
Texas Health Science Center). Although using immortalized cell cultures to does not offer an
exact representation of in vivo neuronal properties, it does offer an alternative means to examine
signaling pathways of interest. Primary cell cultures contain a heterogeneous mixture of cells,
which may make interpreting signal transductions mechanisms difficult. Additionally, the large
amount hypothalamic tissue is required to conduct experiments with primary cultures, would be
costly and require a large number of animals to be sacrificed for each culture.
The purpose of this study was to determine whether known ENaC regulators, such as
insulin and aldosterone, could induce ENaC activity and expression in the 4B hypothalamic cell
line. Over a decade ago the 4B hypothalamic line was generated by immortalizing embryonic
day 19 rat pup hypothalami using a retrovirus-mediated transfer of the SV40 large T-antigen
(Kasckow et al., 2003). 4B cells exhibit a neuronal phenotype and express vasopressin and
corticotrophin releasing factor (CRF) (Kasckow et al., 2003). These cells have been used to
examine CRF and vasopressin gene regulation (Liu et al., 2006; Kageyama et al., 2007;
Kageyama et al., 2014). Additionally, 4B cells express functional glucocorticoid receptor and
CRF type-1 receptors (Kasckow et al., 2003). To test the effects of insulin on ENaC, we
conducted whole-cell electrophysiology and calcium imaging studies in 4B hypothalamic cells
and acutely dissociated vasopressin neurons. Changes in ENaC expression was examined in
aldosterone incubated 4B hypothalamic cells and assessed through qRT-PCR.
Methods
Cell culture
Rat hypothalamic 4B cells (obtained from the laboratory of Dr. T. Cunningham, Texas
Health Science Center) were plated at a density of approximately 5 x 105 in 150-mm Nunc
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culture dishes (Sigma-Aldrich) and grown to confluence then replated in 35 mm Nunc dishes two
days prior to electrophysiology or imaging experiments. Cells were grown in Dulbecco’s
Modified Eagle’s Medium/ Nutrient Mixture F12 Ham’s Liquid media supplemented with 10%
newborn calf serum (Gemini Bio-Products), 1% MEM nonessential amino acids, 1% Glutamax,
1% sodium pyruvate, and 1% Pen-Strep. Cells were serum deprived overnight prior to all
experiments.
Reagents and solutions
All components were purchased from Sigma-Aldrich (St Louis, MO) unless otherwise
stated. The external solution used for calcium imaging and electrophysiology was a modified
artificial cerebral spinal fluid (aCSF) with the following components (in mM): NaCl (143.25),
KCl (2.5), CaCl2 (2), D-glucose (20), HEPES (10), and ascorbic acid (0.4). For experiments
examining effects of high K+, all components remained the same with the exception of KCl (100)
and NaCl (43.25). Internal pipette solution consisted of (in mM): K-gluconate (135), NaCl (10),
HEPES (10), phosphocreatine (10) EGTA (0.1), GTP(Na+) (0.4), and ATP(Mg2+) (2) with a final
pH of 7.31 and 305 mOsmol/L osmolality. Insulin was added to modified aCSF with a final
concentration of 100 nM.
Electrophysiology
Whole- cell voltage clamp recordings were performed using Axopatch 1D amplifier,
Digidata 1322A data-acquisition board, and Clampex 10.0 (Molecular Devices, Sunnyvale, CA).
Patch pipette electrodes with a tip resistance between 5-10 MΩ were pulled from thick-walled
borosilicate glass (1.5 mm O.D., 0.86 I.D.) using a P-97 Flamin/Brown Puller (Sutter
Instruments, Novato, CA). A reference Ag/AgCl electrode pellet was placed in 3 M KCl and
connected to the culture dish with a 3 M KCl agarose bridge. All recordings were performed at
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room temperature and a pressurized perfusion system (AutoMate Sceintific, Berkeley, CA) was
used to deliver external solutions. Cells were grown to approximately 20-30% confluency on a
35 mm Nunc plate.
Immunocytochemistry
Cells were plated at a density of 5 x 10^4 on 18-mm/sq coverslips coated with poly-Dlysine (Sigma-Aldrich). Cells were serum deprived overnight before fixation. The morning of the
experiment, cells were rinsed with sodium phosphate buffered saline (PBS; pH 7.2) and the
media was replaced with 4% paraformaldehyde in PBS for the 30 min to fix the cells at room
temperature. Coverslips were then washed three times with PBS followed by a 1 hr incubation
with 5% normal goat serum in PBS-1% Triton (PBST). Primary antibodies were diluted in PBS
and coverslips were incubated overnight at 4 degrees C. The next day, coverslips were incubated
with the secondary antibody (goat anti-rabbit) conjugated with DyLight 594 (Jackson
ImmunoResearch, West Grove, PA) for 2 hrs at room temperature. The coverslips were washed
three times with PBS and mounted on glass slides using mounting media (Vector Laboratories,
Burlingame, Ca) containing the fluorescent nuclear stain 4’6-diamindino-2-phenlylindole
(DAPI). Images were acquired using a Leica DFCC7000 T Camera (Leica DM6 B Upright
Microscope; Leica Microsystems, Buffalo Grove, IL).
Western blot
Total protein lysate samples were collected from the plated cells. Cells were rinsed with
cold phosphate buffer solution and placed in microcentrifuge tubes containing 250 µl of chilled
complete lysis buffer that was made fresh before each experiment. Complete buffer contained:
RIPA buffer (50 mM NaCl, 1.0% IGEPAL® CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 50
mM Tris, pH 8.0; Sigma-Aldrich), protease inhibitors (ProteoGuardTM EDTA-free protease
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inhibitor cocktail; Takara Clontech), 1 mM EGTA, 1 mM EDTA, and 1mM DTT (SigmaAldrich, St. Louis, MO). Samples were briefly homogenized with an electric tissue lyser
(Qiagen, Valencia, CA) and allowed to stand on ice for 10 min. Lysed samples were centrifuged
for 20 min at 12,000 rpm at 4°C. The pellet was discarded and the supernatant (total lysate) was
transferred to a clean tube to be stored at -20°C for later processing.
The protein concentration was determined (BCA kit; Pierce Chemical Co., Rockford,
Illinois, USA); samples (15-20 µg of protein) were denatured by heating in 1x Laemmli buffer
(Bio-Rad, Hercules, CA) for 5 min at 95 °C. Samples were resolved in a 4-15% SDS-PAGE
(Mini PROTEAN Precast Gels, Bio-Rad, Hercules, CA) gradient gel in Tris-glycine buffer (25
mM, 192 mM glycine, 0.1% SDS, pH 8.3; Bio-Rad) and transferred to a PVDF membrane (BioRad, Hercules, CA) under wet conditions (50V for 2 hr at 4°C). To determine a successful
transfer, the membrane was stained with Ponceau S solution (Sigma-Aldrich, St. Louis, MO) for
approximately 1 min. The membrane was destained with 0.1 M NaOH for 30 sec followed by a 1
min TBST (Tris-GlycineTween; 50 mM Tris base, 200 mM NaCl, 0.05% Tween 20) wash. The
membrane was treated with 5% non-fat milk buffer (NFM; Bio-Rad) for 1 hr at room temp. The
membrane was incubated overnight at 4 °C with the selected primary antibody dissolved in 5%
NFM buffer. A final concentration for all primary antibodies was 1 µg/ml. The membrane was
washed three times for 10 min each with TBST and incubated with Goat- anti Rabbit horseradish
conjugated secondary antibody (1:10,000; Bio-Rad) dissolved in 5% NFM buffer at room temp
for 2 hr followed by six TBST washes for 10 min each. Protein bands were detected through
chemiluminscence reagents (ClarityTM Western ECl Substrate Kit; Bio-Rad) and imaged using a
gel imaging system (ChemiDocTM XRS+; Bio-Rad).
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Calcium imaging
The fluorescent Ca2+ indicator Oregon Green 488 BAPTA-1 AM (OGB; 2 uM, Life
Technologies) was prepared as a 2 mM stock in DMSO. OGB stock and Pluronic F-127 (2.5%
wt/vol in DMSO, Life Technologies) were mixed in a 1:1 ratio and sonicated for 30 sec. OGB
and Pluronic mixture (2 uL) was added to 1 mL of HBSS and briefly vortexed followed by
sonication for 30s. Cells were then incubated with mixture for 1 hr at room temperature in dark
conditions. Following incubation, cells were rinsed with modified aCSF. Sample collection rate
was set for 2 sec intervals with an exposure time of approximately 150 ms. Images were captured
on an inverted Olympus IX70 microscope (Tokyo, Japan) fitted with a SensiCam QE (Cooke,
Kelheim, Germany). Data were collected and analyzed using Slidebook software (Intelligent
Imaging Innovation, Denver, CO). In all calcium imaging experiments, the deltaF/F value was
collected for each treatment. A repeated measures one-way ANOVA to was used for comparison
between treatment groups with a Tukey post-hoc analysis. Differences were considered to be
statistically significant at p< 0.05.
Results
4B hypothalamic cells do not express all ENaC subunits
Preliminary qRT-PCR results indicated that all ENaC subunits and the MR were
expressed in the 4B hypothalamic cell line. Western blot and ICC studies were conducted to
determine if ENaC peptides were also expressed in the cells. Results indicate that the αENaC
subunit peptide was not expressed in this cell line (Fig. 4.1). Our past studies demonstrated that
aldosterone induced ENaC subunit expression and abundance in vasopressin neurons. Initial
experiments were conducted examining aldosterone incubation, but not enough replicates were
collected to account for experimental errors. After incubation with aldosterone or vehicle, qRT-

98

PCR methods were used and the ENaC subunits were no longer detectable. It is possible cells
were not serum deprived long enough and serum growth factors affected the RNA extraction
process.

A

αENaC

βENaC

γENaC

B

*

*

αENaC

βENaC

*

γENaC

Fig. 4.1: 4B hypothalamic cells line does not express the αENaC subunit peptide. A.
Deconvolution image showing the neuronal morphology of the 4B cell line (top right).
Immunocytochemistry staining for all three ENaC subunits showed weak immunoreactivity for
the αENaC subunit and robust staining for the β- and γENaC subunits. B. Completed Western
blots did not detect the αENaC peptide at the appropriate molecular weight (indicated by the red
asterisk) in 4B cells, whereas the β- and γENaC peptides were detected.
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Insulin exposure induces an inward current and increased intracellular Ca2+ in 4B
hypothalamic cells
To examine the electrical properties of the 4B hypothalamic cell line, whole cell patch
voltage clamp experiments were conducted to examine if a ENaC- mediated current was present.
Preliminary studies showed no current change in hypothalamic 4B cells when held at -70 mV
exposed to benzamil, an selective ENaC blocker. Because insulin is a known activator in distal
collecting duct cells, I asked whether insulin exposure would induce an inward, ENaC-mediated
current. In an attempt to induce a detectable current, cells were exposed to 100 nM insulin for 30
seconds while being held at -70 mV (Fig. 4.2). Insulin exposure resulted in an initial small
outward current (denoted by red asterisks) that was quickly followed by a large inward current
(indicated by black arrows) (Fig. 4.2A). Experiments were conducted to block the insulininduced current by benzamil. However, no useable data was collected from these initial studies,
as we were not able to reproducibly produce the insulin-induced current. Further experiments
will need to be conducted to confirm the insulin-induced current is reproducible.
Calcium imaging studies showed that 4B hypothalamic cells exposed to insulin for 30
seconds resulted in a significant increase in intracellular calcium levels (RM ANOVA, p=0.0176;
Fig. 4.2B). Preliminary experiments were conducted to identify the source of the increased
intracellular calcium by using calcium free external media (RM ANOVA, p<0.0001; Fig. 4.2C).
Cells exposed to insulin had a significant increase in intracellular calcium (1± 0.00017)
compared to control levels (0.99877± 0.000163). Mean control values were calculated by
averaging the last ten time points before switching solutions. The cells were then washed with
calcium-free media and exposed to insulin. There was a significant decrease in intracellular
calcium levels from the calcium-free control (0.993± 0.00023) when exposed to insulin (0.9987±
0.00026). The cells were then washed in normal media and exposed to insulin, which caused a
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slight increase in intracellular calcium. To better demonstrate the effects of insulin on
intracellular calcium elevations in 4B hypothalamic cells, an example trace of raw fluorescent
intensities is shown (Fig. 4.3).

Fig. 4.2: Insulin induces inward currents and increases intracellular calcium in 4B hypothalamic
cells. A. Whole cell voltage recordings were conducted in 4B cells and held at -70 mV. Cells
were exposed to 100 nM insulin for 30 seconds, which resulted in an initial outward current (red
asterisks) followed by a large inward current (black arrows). B. Insulin exposure resulted in
elevations in intracellular calcium (n=26). C. Insulin-induced intracellular calcium elevations is
dependent upon extracellular calcium (n=21).
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Fig. 4.3. Raw calcium imaging fluorescent intensities demonstrating effects of insulin in 4B
hypothalamic cells. A representation of raw data measuring exposure of insulin, which resulted
in large intracellular calcium elevations. Insulin exposure is indicated by a red bar.
High K+ solution results in an increase in intracellular Ca2+ in 4B hypothalamic cells
To determine if the 4B hypothalamic cell line expressed voltage gated Ca2+ channels,
cells were exposed to high K+ solution to depolarize the membrane to -20 mV (Fig. 4.4). Cells
exposed to high K+ solution for 10 seconds had a significant increase in intracellular calcium
(1.006 ± 0.0013) compared to control measurements (0.9966 ± 0.0011) (Fig. 4.4A). After
removing the high K+ solution, intracellular calcium levels returned to levels comparable with
the control (0.9968 ± 0.0017). Mean control values were calculated by averaging the last ten time
points before switching solutions. These findings indicate that the 4B cell line has voltage
sensitive calcium channels. Experiments were then conducted using calcium channel blockers to
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confirm the role of calcium channels in the detected response. Lanthanum chloride (LaCl3), a
non-specific calcium channel blocker, was used to elucidate the source of the observed increase
in intracellular calcium during membrane depolarization (RM ANOVA p<0.0001, Fig. 4.4B; see
table for post-hoc values;). Data collected showed no difference in intracellular calcium levels
when the cells were first washed with LaCl3 and then exposed to high K+ + LaCl3 solution,
suggesting external calcium was needed for the observed voltage dependent calcium elevation.
However, once exposed to LaCl3 cells no longer exhibited a response to high K+ solution despite
an extended wash step with normal media for 1 minute. The role of voltage gated calcium
channels was investigated using a selective L-type calcium channel blocker, nifedipine (RM
ANOVA p<0.0001, Fig. 4.4C; see table for post-hoc values). Cells exposed to high K+ solution
showed a significant increase in intracellular calcium (1.002 ± 0.0003) compared to control
measurements (0.9989 ± 0.0001; p<0.0001). After washing the cells with normal media for 1
minute, the cells were then exposed to nifedipine for 30 seconds and the high K+ + nifedipine
solution for 10 seconds. Interestingly, nifedipine and high K+ solution (1.0012 ± 0.0005) caused
a significant decrease in intracellular calcium levels compared to the nifedipine control
measurements (1.0015 ± 0.005; p=0.0315) suggesting that L-type calcium channels are involved
in the observed calcium elevation. After washing the cells with normal medium for 1 minute,
high K+ solution was applied for a second time in an attempt to recover the initial calcium
elevation. However, the second high K+ solution application did not increase intracellular
calcium (1.0004 ± 0.0003), but resulted in a significant decrease compared to the second control
measurement (1.0014 ± 0.00029; p=0.0001). To better demonstrate the effects of insulin on
intracellular calcium elevations in 4B hypothalamic cells, an example trace of raw fluorescent
intensities is shown (Fig. 4.5).
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Fig. 4.4. High K+ solution induces intracellular calcium elevations in 4B hypothalamic cells. A.
Exposure to high K+ solution for 10 seconds depolarized 4B cells to -20 mV and induced
intracellular calcium elevation (n=29). B. LaCl3 exposure prevented intracellular calcium
elevations in 4B cells when exposed to high K+ solution (n=71). C. 4B cells were initially
exposed to high K+ solution resulted in a significant increase in intracellular calcium
(*p<0.0001), whereas nifedipine and high K+ solution resulted in a decrease in intracellular
calcium (**p=0.0315). A second exposure to high K+ solution resulted in a further decrease in
intracellular calcium levels (***p=0.001)(n=27).
To better demonstrate the effects of insulin on intracellular calcium elevations in 4B
hypothalamic cells, an example trace of raw fluorescent intensities is shown (Fig. 4.5). This a
representative trace showing fluorescent traces for 5 4B hypothalamic cells treated with high K+
solution for 10 seconds.
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Fig. 4.5. Raw calcium imaging fluorescent intensities demonstrating effects high K+ solution in
4B hypothalamic cells. A representation of raw data measuring exposure of high K+ solution,
which resulted in large intracellular calcium elevations. High K+ exposure is indicated by a red
bar.
Discussion
The present study was conducted to characterize the 4B hypothalamic cell line and
demonstrated that insulin increases in intracellular calcium and induces an inward current.
Additionally, depolarization with high K+ also increases intracellular calcium, suggesting that
this cell line exhibits voltage sensitive properties. Findings from this study provide insight into
the 4B hypothalamic cell line as a possible model for ENaC regulation.
Although preliminary qRT-PCR data indicated all ENaC subunits and the MR are
expressed in the 4B hypothalamic cell line, further western blot and ICC results did not detect
the αENaC protein. Our past studies demonstrated that aldosterone was able to induce ENaC
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expression and abundance in vasopressin cells (discussed in chapter 2). However, cells incubated
with aldosterone did not have detectable ENaC expression. This could have been caused by
technical error or possible contamination of the cells during the incubation. Additionally, lower
passage number cells should be used to determine if the higher passage number affected mRNA
present.
4B hypothalamic cells exposed to insulin for 30 seconds had in inward current and
increased intracellular calcium. As previously discussed, insulin stimulates ENaC activity and
experiments were performed to determine if benzamil, an ENaC blocker, was able to block the
insulin- induced inward current. Unfortunately, no usable data was obtained because the effect of
insulin could not be reliably reproduced. This is most likely was caused by the passage number
of the cells used in these studies. It has been demonstrated that cells of a higher passage number
have changes in morphology, response to stimuli, and protein expression (Siissalo et al., 2007).
These studies should be repeated in lower passage number cells to ensure consistency in the
observed effect of insulin. Calcium imaging studies, however, did consistently show that cells
exposed to insulin resulted in intracellular calcium elevations. To determine the source of the
increased calcium, cells were exposed to insulin in calcium free media. Interestingly, cells did
not respond to insulin in calcium free media, suggesting that extracellular calcium is the source
of the intracellular calcium elevation. A second application of insulin in normal media did
increase intracellular calcium, but it was not significant. It is possible that cells were not given
enough time to recover so the wash step should be extended.
Exposure to high K+ solution resulted in an increase in intracellular calcium and several
follow-up experiments were conducted to elucidate the channel type involved in the observed
calcium elevation. LaCl3 was used as a non-selective calcium blocker to determine the role of
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calcium channels in intracellular calcium increases. Although the collected results indicate that
extracellular calcium is required for the calcium elevations, cells exposed to LaCl3 no longer
exhibited the previously observed voltage response. The overall experimental design could be
improved upon to further investigate the role of calcium channels. Cells should first be exposed
to normal media and then high K+ solution to ensure that the cells do exhibit a voltage response.
Additionally, the one minute wash step after exposure to LaCl3 may need to be extended to
ensure that the blocker has been completely removed from the cells. Although there was a slight
increase in the intracellular calcium level when the cells were exposed to high K+ solution after
LaCl3 exposure was not a significant increase and may be caused by residual LaCl3.
Nifedipine, a selective L-type calcium channel blocker, was used to examine the role of
these channels in the observed increased intracellular calcium levels in response to membrane
depolarization. Results from this study indicate that L-type calcium channels are involved in the
voltage response in 4B hypothalamic cell line. However, the experimental design should be
modified to provide more accurate results. The duration of the wash steps after each exposure to
high K+ and Nifedipine should be extended. The results suggest that the cells were not given an
adequate amount of time to recover from these exposures. However, results from these
preliminary experiments are promising and should be investigated further.
Using a cell line as a model to investigate signaling pathways and regulatory mechanisms
has many benefits; however, there are several factors that should be considered when designing
experiments and interpreting results. The findings from the preliminary studies conducted
examining the 4B hypothalamic cell line as potential model stresses the importance in
controlling the passage number of the cells used and potential outside containments. Western
blot and immunocytochemistry results indicate that functional ENaCs are not expressed in this
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particular cell line. In order to consider the 4B hypothalamic cell line as a potential model for
ENaC regulation further studies have to be conducted to induce functional channels before
continuing to investigate characteristics of the cell line.
References
Amin MS, Wang H-W, Reza E, Whitman SC, Tuana BS & Leenen FHH. (2005). Distribution of
epithelial sodium channels and mineralocorticoid receptors in cardiovascular regulatory
centers in rat brain. American journal of physiology Regulatory, integrative and
comparative physiology 289, R1787-1797.
Baum M. (1987). Insulin stimulates volume absorption in the rabbit proximal convoluted tubule.
J Clin Invest 79, 1104-1109.
Blazer-Yost BL, Liu X & Helman SI. (1998). Hormonal regulation of ENaCs: insulin and
aldosterone. Am J Physiol 274, C1373-1379.
DeFronzo RA, Goldberg M & Agus ZS. (1976). The effects of glucose and insulin on renal
electrolyte transport. J Clin Invest 58, 83-90.
Escoubet B, Coureau C, Bonvalet JP & Farman N. (1997). Noncoordinate regulation of epithelial
Na channel and Na pump subunit mRNAs in kidney and colon by aldosterone. Am J
Physiol 272, C1482-1491.
Feraille E, Carranza ML, Rousselot M & Favre H. (1994). Insulin enhances sodium sensitivity of
Na-K-ATPase in isolated rat proximal convoluted tubule. Am J Physiol 267, F55-62.
Feraille E, Marsy S, Cheval L, Barlet-Bas C, Khadouri C, Favre H & Doucet A. (1992). Sites of
antinatriuretic action of insulin along rat nephron. Am J Physiol 263, F175-179.
Feraille E, Rousselot M, Rajerison R & Favre H. (1995). Effect of insulin on Na+,K(+)-ATPase
in rat collecting duct. J Physiol 488 ( Pt 1), 171-180.
Fidelman ML & Watlington CO. (1984). Insulin and aldosterone interaction on NA+ and K+
transport in cultured kidney cells (A6). Endocrinology 115, 1171-1178.
Ito O, Kondo Y, Oba M, Takahashi N, Omata K & Abe K. (1997). Tyrosine kinase,
phosphatidylinositol 3-kinase, and protein kinase C regulate insulin-stimulated NaCl
absorption in the thick ascending limb. Kidney Int 51, 1037-1041.
Johnson JP, Jones D & Wiesmann WP. (1986). Hormonal regulation of Na+-K+-ATPase in
cultured epithelial cells. Am J Physiol 251, C186-190.

108

Kageyama K, Hanada K, Iwasaki Y, Sakihara S, Nigawara T, Kasckow J & Suda T. (2007).
Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing
factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells. J
Endocrinol 195, 199-211.
Kageyama K, Itoi K, Iwasaki Y, Niioka K, Watanuki Y, Yamagata S, Nakada Y, Das G, Suda T
& Daimon M. (2014). Stimulation of corticotropin-releasing factor gene expression by
FosB in rat hypothalamic 4B cells. Peptides 51, 59-64.
Kasckow J, Mulchahey JJ, Aguilera G, Pisarska M, Nikodemova M, Chen HC, Herman JP,
Murphy EK, Liu Y, Rizvi TA, Dautzenberg FM & Sheriff S. (2003). Corticotropinreleasing hormone (CRH) expression and protein kinase A mediated CRH receptor
signalling in an immortalized hypothalamic cell line. J Neuroendocrinol 15, 521-529.
Liu Y, Kalintchenko N, Sassone-Corsi P & Aguilera G. (2006). Inhibition of corticotrophinreleasing hormone transcription by inducible cAMP-early repressor in the hypothalamic
cell line, 4B. J Neuroendocrinol 18, 42-49.
MacDonald P, MacKenzie S, Ramage LE, Seckl JR & Brown RW. (2000). Corticosteroid
regulation of amiloride-sensitive sodium-channel subunit mRNA expression in mouse
kidney. J Endocrinol 165, 25-37.
Mandon B, Siga E, Chabardes D, Firsov D, Roinel N & De Rouffignac C. (1993). Insulin
stimulates Na+, Cl-, Ca2+, and Mg2+ transports in TAL of mouse nephron: crosspotentiation with AVP. Am J Physiol 265, F361-369.
Mansley MK, Watt GB, Francis SL, Walker DJ, Land SC, Bailey MA & Wilson SM. (2016).
Dexamethasone and insulin activate serum and glucocorticoid-inducible kinase 1 (SGK1)
via different molecular mechanisms in cortical collecting duct cells. Physiological
reports 4.
Marunaka Y, Hagiwara N & Tohda H. (1992). Insulin activates single amiloride-blockable Na
channels in a distal nephron cell line (A6). Am J Physiol 263, F392-400.
Masilamani S, Kim GH, Mitchell C, Wade JB & Knepper MA. (1999). Aldosterone-mediated
regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. J Clin Invest
104, R19-23.
Miller JH & Bogdonoff MD. (1954). Antidiuresis associated with administration of insulin. J
Appl Physiol 6, 509-512.
Renard S, Voilley N, Bassilana F, Lazdunski M & Barbry P. (1995). Localization and regulation
by steroids of the alpha, beta and gamma subunits of the amiloride-sensitive Na+ channel
in colon, lung and kidney. Pflugers Arch 430, 299-307.

109

Siissalo S, Laitinen L, Koljonen M, Vellonen KS, Kortejarvi H, Urtti A, Hirvonen J & Kaukonen
AM. (2007). Effect of cell differentiation and passage number on the expression of efflux
proteins in wild type and vinblastine-induced Caco-2 cell lines. Eur J Pharm Biopharm
67, 548-554.
Stokes JB & Sigmund RD. (1998). Regulation of rENaC mRNA by dietary NaCl and steroids:
organ, tissue, and steroid heterogeneity. Am J Physiol 274, C1699-1707.
Veelken R, Schelling P & Unger T. (1988). An approach to measuring cardiac output with
Doppler flow probes in conscious rats. Am J Physiol 255, H1206-1210.
Wang J, Barbry P, Maiyar AC, Rozansky DJ, Bhargava A, Leong M, Firestone GL & Pearce D.
(2001). SGK integrates insulin and mineralocorticoid regulation of epithelial sodium
transport. Am J Physiol Renal Physiol 280, F303-313.

110

CHAPTER 5
CONCLUSION
Approximately 30% of the American population suffers from salt-sensitivity, which
causes individuals to have increased risks of morbidity and mortality (Franco & Oparil, 2006).
Elucidating the mechanism and regulatory pathway involved in salt-sensitive hypertension
development is necessary to contribute to pharmacological therapies to treat individuals with this
disease. As there is a growing amount of evidence to suggest that abnormal regulation of central
ENaC in salt-sensitivity, we sought to examine the regulation of ENaC expression in vasopressin
neurons in the hypothalamus of normotensive and salt-sensitive animals.
In the second chapter, we were the first to show that aldosterone binds to the MR to
regulate specifically the γENaC subunit expression and abundance in vasopressin neurons.
Additionally, it was demonstrated that the aldosterone-MR complex directly interacts with the
promoter region of the γENaC gene. Aldosterone, however, did not affect the ENaC-mediated
current or subcellular distribution. This finding suggests that additional regulatory factors are
required to influence ENaC trafficking and activity. Corticosterone effects on ENaC expression
were also examined, and we found increased γENaC expression specifically through binding the
GR. Together these results provide insights into the regulation of ENaC of expression and
activity in vasopressin neurons.
In the third chapter, the effects of dietary salt on ENaC expression in vasopressin neurons
and the kidneys in salt-sensitive animals were accessed. Dahl-SS rats, regardless of diet, have
higher γENaC abundance in the hypothalamus. Additionally, consumption of high dietary salt
resulted in increased γENaC expression and proteolytic cleavage of the subunit. In contrast,
normotensive rats fed high dietary salt had decreased MR expression in the hypothalamus and
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αENaC expression in the kidneys. This is the first time that a potential compensatory mechanism
has been demonstrated in how normotensive individuals may prevent salt-induced hypertension
development.
In the fourth chapter, the 4B hypothalamic cell line was characterized and investigated as
a potential model to further investigate ENaC regulation. Preliminary studies from these
experiments found that functional ENaCs are not expressed in these cells. Interestingly, insulin
exposure resulted in an inward current and increased intracellular calcium levels. Initial findings
suggest that this effect is dependent upon extracellular calcium. Additionally, exposing high K+
solution to depolarize the cells resulted in increased intracellular calcium. Pharmacological
studies suggested that this voltage response involves L-type calcium channels. Further studies
are needed to provide insight into this cell line and its potential use as a model for ENaC
regulation.
As the exact mechanism that mediates central ENaC expression and activity during salt
sensitive states remains unknown, results from the above mentioned studies provide some insight
into compensatory mechanisms involving ENaC to counteract hypertension development and the
hormones potentially responsible for the abnormal ENaC regulation during salt sensitivity.
Investigation into hormonal regulation of ENaC (Gomez-Sanchez et al., 2005)expression in
vasopressin neurons revealed two distinct regulatory pathways involving aldosterone and
corticosterone activating the MR and glucocorticoid receptor, respectively. Studies conducted
previously in the Teruyama Lab found that magnocellular neurons, including vasopressinsynthesizing neurons, are considered aldosterone sensitive due to the presence of 11β -HSD2
(Haque et al., 2015), a glucocorticoid-inactivating enzyme (Gomez-Sanchez et al., 2005). This
indicates that aldosterone binding to the MR is most likely the primary regulator of ENaC
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expression in vasopressin neurons. Further experiments using an in vivo approach involving
animals receiving ICV injections of aldosterone would provide physiological data to supplement
the transcriptional effect aldosterone has on ENaC expression in vasopressin neurons.
The compensatory mechanism observed in normotensive animals fed high dietary salt
provides insight to the etiology of salt-sensitivity and hypertension development. Additional
experiments are needed to examine the physiological response salt-sensitive animals have when
fed high dietary salt. Plasma vasopressin levels should be examined in addition to plasma
osmolality. As systemic release of vasopressin is directly correlated to the firing activity of the
synthesizing neuron (Poulain & Wakerley, 1982), plasma vasopressin levels would provide
insight into the neuronal activity during salt-sensitive states. Electrophysiological studies also
have to be conducted to examine ENaC activity in vasopressin neurons during salt-sensitive
states. Our finding that salt- sensitive animals have higher γENaC abundance compared to
normotensive animals suggest that ENaC activity in vasopressin activity is altered regardless of
dietary treatment. Given the role the γENaC subunit has in mediating channel surface expression
and function (Konstas & Korbmacher, 2003), it is likely that salt-sensitive individuals have
higher basal level ENaC activity. Additionally, electrophysiology experiments have to be
completed in salt-sensitive animals fed high salt diet to determine if the presence of the
proteolytic form of the γENaC subunit increases vasopressin neuronal activity. Further
physiological parameters, such as mean arterial pressure, should be assessed in salt-sensitive
animals. Using telemetry methods, salt-sensitive animals should exhibit increased mean arterial
pressure that corresponds to the observed increased plasma osmolality. These experiments are
necessary to provide a full understanding of how genomic changes in hypothalamic ENaC
expression has broader, systemic effects.
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The mechanism mediating ENaC activity and expression at the level of the kidney is
complex and involves numerous secondary messengers and hormones (discussed in Chapter 1).
It is likely that the regulatory component, in addition to the MR and aldosterone, are altered in
salt-sensitive states. Specifically, expression and activity of 11β-HSD2 should also be assessed.
It is possible that 11β-HSD2 expression is higher in the SON and PVN in salt-sensitive animals,
which may contribute to further activation of the MR via aldosterone binding. Interestingly,
syndrome of apparent mineralocorticoid excess, an autosomal form of salt-sensitivity, is caused
by a deficiency in 11β-HSD2 at the level of the kidney (Mune et al., 1995; Kotelevtsev et al.,
1999). Although it as not been investigated in the central nervous system, it would provide
helpful information to investigate the role of 11β-HSD2 in vasopressin neurons during saltsensitive states.
Hypertension continues to affect a growing number of individuals in industrialized
countries and is a major risk factor for cardiovascular events and death (Writing Group et al.,
2016). Although the full regulatory mechanism of central ENaC expression remains incomplete,
findings from our studies provide insight into the abnormal hypothalamic ENaC regulation that
may contribute to salt-sensitive hypertension development. Further studies should be conducted
to investigate the involvement of the different regulatory pathways and mechanisms that results
in an individual being susceptible to salt-sensitive hypertension.
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